<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Quinine for muscle cramps - El‐Tawil, S - 2015 | Cochrane Library</title> <meta content="Quinine for muscle cramps - El‐Tawil, S - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005044.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Quinine for muscle cramps - El‐Tawil, S - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005044.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005044.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Quinine for muscle cramps" name="citation_title"/> <meta content="Sherif El‐Tawil" name="citation_author"/> <meta content="PO Box 114, National Hospital for Neurology and Neurosurgery" name="citation_author_institution"/> <meta content="cochranenmd@ion.ucl.ac.uk" name="citation_author_email"/> <meta content="Tarique Al Musa" name="citation_author"/> <meta content="St Georges Hospital NHS Trust" name="citation_author_institution"/> <meta content="Haseeb Valli" name="citation_author"/> <meta content="Homerton University Hospital" name="citation_author_institution"/> <meta content="Michael PT Lunn" name="citation_author"/> <meta content="National Hospital for Neurology and Neurosurgery" name="citation_author_institution"/> <meta content="Ruth Brassington" name="citation_author"/> <meta content="National Hospital for Neurology and Neurosurgery" name="citation_author_institution"/> <meta content="Tariq El‐Tawil&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Markus Weber" name="citation_author"/> <meta content="Kantonsspital St. Gallen" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD005044.pub3" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/04/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005044.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005044.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005044.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Drug Therapy, Combination; Lidocaine [therapeutic use]; Muscle Cramp [*drug therapy]; Muscle Relaxants, Central [adverse effects, *therapeutic use]; Quinine [adverse effects, *therapeutic use]; Randomized Controlled Trials as Topic; Theophylline [therapeutic use]; Vitamin E [therapeutic use]; Vitamins [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005044.pub3&amp;doi=10.1002/14651858.CD005044.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="uYcNEb5O";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005044\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005044\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ja","hr","pl","ta","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005044.pub3",title:"Quinine for muscle cramps",firstPublishedDate:"Apr 5, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neuromuscular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uYcNEb5O&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005044.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005044.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005044.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005044.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005044.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005044.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ta&quot;,&quot;title&quot;:&quot;எளியமொழிச் சுருக்கம்&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005044.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005044.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005044.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005044.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6028 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005044.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-sec-0099"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-sec-0045"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-sec-0089"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/appendices#CD005044-sec-0104"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/table_n/CD005044StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/table_n/CD005044StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Quinine for muscle cramps</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information#CD005044-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Sherif El‐Tawil</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information#CD005044-cr-0003">Tarique Al Musa</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information#CD005044-cr-0004">Haseeb Valli</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information#CD005044-cr-0005">Michael PT Lunn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information#CD005044-cr-0006">Ruth Brassington</a></li> <li class="author custom-tooltip" title="Deceased"><a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information#CD005044-cr-0007">Tariq El‐Tawil</a><sup>a</sup></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information#CD005044-cr-0008">Markus Weber</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information/en#CD005044-sec-0113">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 April 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005044.pub3">https://doi.org/10.1002/14651858.CD005044.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005044-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005044-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005044-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005044-abs-0009">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005044-abs-0001" lang="en"> <section id="CD005044-sec-0001"> <h3 class="title" id="CD005044-sec-0001">Background</h3> <p>Muscle cramps can occur anywhere and for many reasons. Quinine has been used to treat cramps of all causes. However, controversy continues about its efficacy and safety. This review was first published in 2010 and searches were updated in 2014. </p> </section> <section id="CD005044-sec-0002"> <h3 class="title" id="CD005044-sec-0002">Objectives</h3> <p>To assess the efficacy and safety of quinine‐based agents in treating muscle cramps.</p> </section> <section id="CD005044-sec-0003"> <h3 class="title" id="CD005044-sec-0003">Search methods</h3> <p>On 27 October 2014 we searched the Cochrane Neuromuscular Disease Group Specialized Register, CENTRAL, MEDLINE and EMBASE. We searched reference lists of articles up to 2014. We also searched for ongoing trials in November 2014. </p> </section> <section id="CD005044-sec-0004"> <h3 class="title" id="CD005044-sec-0004">Selection criteria</h3> <p>Randomised controlled trials of people of all ages with muscle cramps in any location and of any cause, treated with quinine or its derivatives. </p> </section> <section id="CD005044-sec-0005"> <h3 class="title" id="CD005044-sec-0005">Data collection and analysis</h3> <p>Three review authors independently selected trials for inclusion, assessed risk of bias and extracted data. We contacted study authors for additional information. For comparisons including more than one trial, we assessed the quality of the evidence using Grading of Recommendations Assessment, Development and Evaluation (GRADE). </p> </section> <section id="CD005044-sec-0006"> <h3 class="title" id="CD005044-sec-0006">Main results</h3> <p>We identified 23 trials with a total of 1586 participants. Fifty‐eight per cent of these participants were from five unpublished studies. Quinine was compared to placebo (20 trials, n = 1140), vitamin E (four trials, n = 543), a quinine‐vitamin E combination (three trials, n = 510), a quinine‐theophylline combination (one trial, n = 77), and xylocaine injections into the gastrocnemius muscle (one trial, n = 24). The most commonly used quinine dosage was 300 mg/day (range 200 to 500 mg). We found no new trials for inclusion when searches were updated in 2014. </p> <p>The risk of bias in the trials varied considerably. All 23 trials claimed to be randomised, but only a minority described randomisation and allocation concealment adequately. </p> <p>Compared to placebo, quinine significantly reduced cramp number over two weeks by 28%, cramp intensity by 10%, and cramp days by 20%. Cramp duration was not significantly affected. </p> <p>A significantly greater number of people suffered minor adverse events on quinine than placebo (risk difference (RD) 3%, 95% confidence interval (CI) 0% to 6%), mainly gastrointestinal symptoms. Overdoses of quinine have been reported elsewhere to cause potentially fatal adverse effects, but in the included trials there was no significant difference in major adverse events compared with placebo (RD 0%, 95% CI ‐1% to 2%). One participant suffered from thrombocytopenia (0.12% risk) on quinine. </p> <p>A quinine‐vitamin E combination, vitamin E alone, and xylocaine injections into gastrocnemius were not significantly different to quinine across all outcomes, including adverse effects. Based on a single trial comparison, quinine alone was significantly less effective than a quinine‐theophylline combination but with no significant differences in adverse events. </p> </section> <section id="CD005044-sec-0007"> <h3 class="title" id="CD005044-sec-0007">Authors' conclusions</h3> <p>There is low quality evidence that quinine (200 mg to 500 mg daily) significantly reduces cramp number and cramp days and moderate quality evidence that quinine reduces cramp intensity. There is moderate quality evidence that with use up to 60 days, the incidence of serious adverse events is not significantly greater than for placebo in the identified trials, but because serious adverse events can be rarely fatal, in some countries prescription of quinine is severely restricted. </p> <p>Evidence from single trials suggests that theophylline combined with quinine improves cramps more than quinine alone, and the effects of xylocaine injections into gastrocnemius are not significantly different to quinine across all outcomes. Low or moderate quality evidence shows no significant difference between quinine and vitamin E or quinine and quinine‐vitamin E mixture. Further research into these alternatives, as well other pharmacological and non‐pharmacological treatments, is thus warranted. </p> <p>There is no evidence to judge optimal dosage or duration of quinine treatment. Further studies using different dosages and measurement of serum quinine levels will allow a therapeutic range to be defined for muscle cramp. Because serious adverse events are not common, large population studies are required to more accurately inform incidence. Longer lengths of follow‐up in future trials will help determine the duration of action following cessation of quinine as well as long‐term adverse events. The search for new therapies, pharmacological and nonpharmacological, should continue and further trials should compare vitamin E, quinine‐vitamin E combination, and quinine‐theophylline mixture with quinine. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005044-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005044-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005044-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005044-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD005044-abs-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD005044-abs-0003">日本語</a> </li> <li class="section-language"> <a class="" href="full/pl#CD005044-abs-0005">Polski</a> </li> <li class="section-language"> <a class="" href="full/ta#CD005044-abs-0006">தமிழ்</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005044-abs-0002" lang="en"> <h3>Quinine for muscle cramps</h3> <p><b>Review question</b> </p> <p>We reviewed the evidence about the effect of quinine on muscle cramps.</p> <p><b>Background</b> </p> <p>Muscle cramps can occur anywhere and in anyone; however, leg cramps are especially common in older people. Quinine is a medicine which has been used to treat cramps for many years. There is conflicting evidence for its ability to reduce cramps. Quinine can cause serious, even fatal adverse events, especially in overdosage. </p> <p><b>Study characteristics</b> </p> <p>This review includes 23 trials, with 1586 participants. The trials compared quinine or quinine‐based medicines against inactive treatment (placebo) or other active treatments. We found no new studies when we searched the medical literature again and updated the review in 2014. </p> <p><b>Key results and quality of the evidence</b> </p> <p>The risk of bias in the included trials varied considerably. All 23 trials claimed to be randomised, but many failed to clearly describe how participants were assigned to treatments. There is low quality evidence that quinine (200 mg to 500 mg daily) significantly reduces cramp number and cramp days and moderate quality evidence that quinine reduces cramp intensity. There is moderate quality evidence that there are more minor adverse events with quinine compared to placebo but no increase in major adverse events. However, there are reliable reports from other sources that an overdose of quinine can cause serious harm including death. </p> <p>Low or moderate quality evidence shows there is no significant difference when comparing quinine to vitamin E or to a quinine‐vitamin E mixture. There is evidence from one trial that theophylline combined with quinine improves cramps more than quinine alone. In a single trial there was no significant difference when comparing quinine to xylocaine injections. </p> <p>More research is needed to clarify the best dose and duration of treatment, as well as alternatives to quinine for cramps. </p> <p>The evidence is current to October 2014.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005044-sec-0099" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005044-sec-0099"></div> <h3 class="title" id="CD005044-sec-0100">Implications for practice</h3> <section id="CD005044-sec-0100"> <p>There is low quality evidence that quinine (200 mg to 500 mg daily) significantly reduces cramp number and cramp days and moderate quality evidence that quinine reduces cramp intensity. Evidence from single trials suggests that theophylline combined with quinine improves cramps more than quinine alone and the effects of xylocaine injections into gastrocnemius are not significantly different to quinine across all outcomes. Low or moderate quality evidence shows no significant difference between quinine and vitamin E (four trials) or quinine and quinine‐vitamin E mixture (three trials). Major adverse events are rare with quinine (moderate quality evidence) but can be serious or fatal so that in some countries prescription of quinine is severely restricted. There is no evidence to judge optimal dosage or duration of quinine treatment. </p> </section> <h3 class="title" id="CD005044-sec-0101">Implications for research</h3> <section id="CD005044-sec-0101"> <p>The optimum dose and duration of quinine treatment require elucidation. Measurement of serum quinine levels will allow a therapeutic range to be defined for muscle cramp. Longer lengths of follow‐up in trials will help determine the duration of its action following cessation as well as long‐term adverse events. Because serious adverse events are not common, large population studies are required to more accurately inform incidence. The search for new therapies, pharmacological and nonpharmacological, should continue and further trials should compare vitamin E, quinine‐vitamin E combination, and quinine‐theophylline mixture with quinine. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005044-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005044-sec-0015"></div> <div class="table" id="CD005044-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Quinine versus placebo for muscle cramps</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quinine for muscle cramps</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with muscle cramps<br/> <b>Settings:</b> mainly outpatients<br/> <b>Intervention:</b> quinine versus placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Quinine </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of cramps over 2 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the control groups was<br/> <b>8.8 cramps</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the intervention groups was<br/> <b>2.45 lower</b> <br/> (1.36 to 3.54 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>952<br/> (13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cramp intensity</b> <br/> (on 3‐point scale; 1 = mild; 2 = moderate; 3 = severe) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the control groups was<br/> <b>1.2 units</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the intervention groups was<br/> <b>0.12 lower</b> <br/> (0.2 to 0.05 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>666<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering major adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>14 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> (4 to 35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1103<br/> (18 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences. The difference was not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering minor adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>94 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>127 per 1000</b> <br/> (94 to 154) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>969<br/> (16 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences. The difference was statistically significant. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>There were significant shortcomings in study design in some trials, but the majority of those included in this meta‐analysis were of moderate to high quality, warranting a single downgrading for limitations in design and implementation. We further downgraded the evidence for this outcome to low quality because of the heterogeneity of the results.<sup>2</sup>Major adverse events were defined as those being severe enough to warrant participant withdrawal from the trial. As specific hypersensitivity reactions are so rare, larger studies are needed to clarify the incidence of such adverse events in particular. Some trials did not prespecify adverse events as an outcome but simply reported them retrospectively, thus compromising slightly on the quality of evidence.<br/> <sup>3</sup>Minor adverse events were defined as being those that did not warrant participant withdrawal from the trial. Some trials did not prespecify adverse events as an outcome but simply reported them retrospectively, thus compromising slightly on the quality of evidence. Otherwise, a well‐reported outcome. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005044-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Quinine versus vitamin E for muscle cramps</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quinine versus vitamin E for muscle cramps</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with muscle cramps<br/> <b>Settings:</b> outpatients<br/> <b>Intervention:</b> quinine versus vitamin E </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Vitamin E</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Quinine </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of cramps over 2 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the control groups was<br/> <b>7.22</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the intervention groups was<br/> <b>0.24 lower</b> <br/> (1.29 lower to 0.81 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>513<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cramp intensity</b> <br/> (on 3‐point scale; 1 = mild; 2 = moderate; 3 = severe) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the control groups was<br/> <b>1.04 units</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the intervention groups was<br/> <b>0.06 lower</b> <br/> (0.17 lower to 0.04 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>513<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering major adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>9 per 1000</b> <br/> (‐8 to 25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>513<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences. The difference between the 2 groups was not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering minor adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>189 per 1000</b> <br/> (127 to 257) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>483<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences. The difference between the 2 groups was not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Only 3 trials were available for this comparison, 2 of which were conducted by pharmaceutical investigators on behalf of manufacturers of quinine. A deficiency in the design of 1 of these trials meant that there was only a 2‐day washout between cross‐over treatments.<br/> <sup>2</sup>The effect on cramp number was inconsistent among the 3 included trials.<br/> <sup>3</sup>Only 2 studies were available for this comparison; 1 of them having a very short washout period (2 days) between treatments. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005044-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Quinine versus a quinine‐vitamin E combination (Q‐Vel) for muscle cramps</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quinine versus a quinine‐vitamin E combination (Q‐Vel) for muscle cramps</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with muscle cramps<br/> <b>Settings:</b> outpatients<br/> <b>Intervention:</b> quinine versus a quinine‐vitamin E combination (Q‐Vel) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Quinine‐vitamin E combination (Q‐Vel)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Quinine </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of cramps over 2 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the control groups was<br/> <b>8.37</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the intervention groups was<br/> <b>1.07 higher</b> <br/> (1.08 lower to 3.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>486<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cramp intensity</b> <br/> (on 3‐point scale; 1 = mild; 2 = moderate; 3 = severe) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the control groups was<br/> <b>0.87 units</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the intervention groups was<br/> <b>0.1 higher</b> <br/> (0.06 lower to 0.26 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>510<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering major adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> <br/> (‐2 to 18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>510<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering minor adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>173 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>202 per 1000</b> <br/> (133 to 273) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>510<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences. The difference was not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The results for cramp number in these 2 trials were not consistent, each suggesting opposite effects.<br/> <sup>2</sup>Only 2 studies were available for this comparison. Both were conducted by pharmaceutical investigators on behalf of manufacturers of quinine and the quinine‐vitamin E combination.<br/> <sup>3</sup>All 3 trials were conducted by pharmaceutical companies who manufacture quinine and the quinine‐vitamin E combination.<br/> <sup>4</sup>There was no consistency between the results for intensity in these 3 trials. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005044-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005044-sec-0016"></div> <section id="CD005044-sec-0017"> <h3 class="title" id="CD005044-sec-0017">Description of the condition</h3> <p>Muscle cramps are sudden episodes of painful involuntary muscle contractions that may be visible or palpable (<a href="./references#CD005044-bbs2-0035" title="BaldisseraF , CavallariP , DworzakF . Motor neuron 'bistability'. A pathogenetic mechanism for cramps and myokymia. Brain1994;117(Pt 5):929‐39. ">Baldissera 1994</a>). Episodes may last seconds or several minutes but are usually self limiting. The severity and duration of each attack varies from person to person, as does their frequency. They are a common distressing occurrence in elderly people. It has been estimated that between 33% and 50% of elderly people suffer from regular leg cramps (<a href="./references#CD005044-bbs2-0030" title="AbdullaAJ , JonesPW , PearceVR . Leg cramps in the elderly: prevalence, drug and disease associations. International Journal of Clinical Practice1999;53(7):494‐6. ">Abdulla 1999</a>; <a href="./references#CD005044-bbs2-0085" title="NaylorRJ , YoungJB . A general population survey of leg cramps. Age and Ageing1994;23(5):418‐20. ">Naylor 1994</a>). Muscle cramps can occur at any time and in any body part, but frequently they occur at night in the legs. Most cases seem to be idiopathic (with no obvious underlying cause). </p> <p>There are no explicit diagnostic criteria for muscle cramp or indeed a universally accepted definition. Despite its frequency and associated morbidity there has been relatively little research into its cause, treatment or prevention. </p> <p>The aetiology of muscle cramp is unknown, and the many proposed mechanistic causes are speculative. Two principal mechanisms have been proposed. In one, the motor nerve terminals are abnormally excitable; in the other, groups of anterior horn cells may be unstable due to spinal disinhibition leading to explosive hyperactivity of motor neurons and consequent high‐frequency discharges of several motor units (<a href="./references#CD005044-bbs2-0035" title="BaldisseraF , CavallariP , DworzakF . Motor neuron 'bistability'. A pathogenetic mechanism for cramps and myokymia. Brain1994;117(Pt 5):929‐39. ">Baldissera 1994</a>; <a href="./references#CD005044-bbs2-0059" title="JansenPH , JoostenEM , VingerhoetsHM . Muscle cramp: main theories as to aetiology. European Archives of Psychiatry &amp; Neurological Sciences1990;239(5):337‐42. ">Jansen 1990</a>; <a href="./references#CD005044-bbs2-0067" title="LayzerRB . The origin of muscle fasciculations and cramps. Muscle and Nerve1994;17(11):1243‐9. ">Layzer 1994</a>). In symptomatic cramps, the pathophysiology may differ according to the underlying cause. </p> <p>Suggested risk factors include motor neuron disease, peripheral neuropathy, radiculopathy, electrolyte disturbances, haemodialysis, uraemia, liver cirrhosis, hypothyroidism, as well as pregnancy and vigorous exercise (<a href="./references#CD005044-bbs2-0080" title="MillerTM , LayzerRB . Muscle cramps. Muscle and Nerve2005;32(4):431‐42. ">Miller TM 2005</a>). Medications have also been implicated including diuretics, nifedipine, steroids, beta‐adrenoreceptor agonists, morphine and statins (<a href="./references#CD005044-bbs2-0044" title="EatonJM . Is this really a muscle cramp?. Postgraduate Medical Journal1989;86(3):227‐32. ">Eaton 1989</a>; <a href="./references#CD005044-bbs2-0056" title="HaskellSG , FiebachNH . Clinical epidemiology of nocturnal leg cramps in male veterans. American Journal of the Medical Sciences1997;313(4):210‐14. ">Haskell 1997</a>; <a href="./references#CD005044-bbs2-0075" title="McGeeSR . Muscle cramps. Archives of Internal Medicine1990;150(3):511‐18. ">McGee 1990</a>). </p> <p>Without a clear understanding of aetiology or pathophysiology, treatments have been empirical. It has been recommended that muscle cramps are treated by nonpharmacological interventions before any medications are commenced (<a href="./references#CD005044-bbs2-0041" title="ButlerJV , MulkerrinEC , O'KeeffeST . Nocturnal leg cramps in older people. Postgraduate Medical Journal2002;78(924):596‐8. ">Butler 2002</a>). There is, however a significant paucity of good quality data on non‐drug therapies for cramp (<a href="./references#CD005044-bbs2-0039" title="BlytonF , ChuterV , WalterKE , BurnsJ . Non‐drug therapies for lower limb muscle cramps. Cochrane Database of Systematic Reviews2012, Issue 1. [DOI: 10.1002/14651858.CD008496.pub2] ">Blyton 2012</a>; <a href="./references#CD005044-bbs2-0054" title="HallegraeffJM , Van derSchansCP , DeRuiterR , DeGreefMH . Stretching before sleep reduces the frequency and severity of nocturnal leg cramps in older adults: a randomised trial. Journal of Physiotherapy2012;58(1):17‐22. ">Hallegraeff 2012</a>). Drugs utilised to prevent muscle cramp include vitamin E (<a href="./references#CD005044-bbs2-0034" title="AyresSJr , MihanR . Nocturnal leg cramps (systremma): a progress report on response to vitamin E. Southern Medical Journal1974;67(11):1308‐12. ">Ayres 1974</a>), calcium channel blockers (<a href="./references#CD005044-bbs2-0024" title="BaltodanoN , GalloBV , WeidlerDJ . Verapamil vs quinine in recumbent nocturnal leg cramps in the elderly. Archives of Internal Medicine1988;148(9):1969‐70. ">Baltodano 1988</a>; <a href="./references#CD005044-bbs2-0092" title="PeerG , BlumM , AviramA . Relief of hemodialysis‐induced muscular cramps by nifedipine. Dialysis and Transplantation1983;12:180‐1. ">Peer 1983</a>), naftidrofuryl oxalate (<a href="./references#CD005044-bbs2-0101" title="YoungJB , ConnollyMJ . Naftidrofuryl treatment for rest cramp. Postgraduate Medical Journal1993;69:624‐6. ">Young 1993</a>), orphenadrine citrate (<a href="./references#CD005044-bbs2-0066" title="LattaD , TurnerE . An alternative to quinine in nocturnal leg cramps. Current Therapeutic Research, Clinical and Experimental1989;45:833‐7. ">Latta 1989</a>), magnesium sulphate (<a href="./references#CD005044-bbs2-0043" title="DahleLO , BergG , HammarM , HurtigM , LarssonL . The effect of oral magnesium substitution on pregnancy‐induced leg cramps. American Journal of Obstetrics and Gynecology1995;173(1):175‐80. ">Dahle 1995</a>; <a href="./references#CD005044-bbs2-0050" title="GarrisonSR , AllanGM , SekhonRK , MusiniVM , KhanKM . Magnesium for skeletal muscle cramps. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD009402.pub2] ">Garrison 2012</a>; <a href="./references#CD005044-bbs2-0102" title="YoungGL , JewellD . Interventions for leg cramps in pregnancy. Cochrane Database of Systematic Reviews2002, Issue 1. [DOI: 10.1002/14651858.CD000121] ">Young 2002</a>), and quinine (<a href="./references#CD005044-bbs2-0012" title="JonesK , CastledenCM . A double‐blind comparison of quinine sulphate and placebo in muscle cramps. Age and Ageing1983;12(2):155‐8. [PUBMED: 6346830] ">Jones 1983</a>).<br/> <br/> Vitamin E was considered effective in reducing cramps in three trials (<a href="./references#CD005044-bbs2-0033" title='AyresSJr , MihanR . Leg cramps (systremma) and "restless legs" syndrome. Response to vitamin E (tocopherol). California Medicine1969;111(2):87‐91. '>Ayres 1969</a>; <a href="./references#CD005044-bbs2-0034" title="AyresSJr , MihanR . Nocturnal leg cramps (systremma): a progress report on response to vitamin E. Southern Medical Journal1974;67(11):1308‐12. ">Ayres 1974</a>; <a href="./references#CD005044-bbs2-0062" title="KhajehdehiP , MojerlouM , BehzadiS , Rais‐JalaliGA . A randomized, double‐blind, placebo‐controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps. Nephrology Dialysis Transplantation2001;16(7):1448‐51. ">Khajehdehi 2001</a>), but not in another (<a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>). Verapamil was tested in an uncontrolled trial of eight participants who were refractory to quinine treatment (<a href="./references#CD005044-bbs2-0024" title="BaltodanoN , GalloBV , WeidlerDJ . Verapamil vs quinine in recumbent nocturnal leg cramps in the elderly. Archives of Internal Medicine1988;148(9):1969‐70. ">Baltodano 1988</a>). Of these eight, seven reported an improvement in their cramp symptoms over an eight‐week treatment period. Naftidrofuryl oxalate, a vasodilator, significantly reduced the frequency of cramps in a randomised control trial (RCT) involving 14 participants (<a href="./references#CD005044-bbs2-0101" title="YoungJB , ConnollyMJ . Naftidrofuryl treatment for rest cramp. Postgraduate Medical Journal1993;69:624‐6. ">Young 1993</a>). Orphenadrine citrate, an anticholinergic with muscle relaxant properties, significantly reduced the frequency of cramps in a group of 59 participants in a double‐blind cross‐over trial (<a href="./references#CD005044-bbs2-0066" title="LattaD , TurnerE . An alternative to quinine in nocturnal leg cramps. Current Therapeutic Research, Clinical and Experimental1989;45:833‐7. ">Latta 1989</a>). Though magnesium salts have been shown to be effective in relieving the subjective distress caused by cramps in pregnancy (<a href="./references#CD005044-bbs2-0043" title="DahleLO , BergG , HammarM , HurtigM , LarssonL . The effect of oral magnesium substitution on pregnancy‐induced leg cramps. American Journal of Obstetrics and Gynecology1995;173(1):175‐80. ">Dahle 1995</a>; <a href="./references#CD005044-bbs2-0102" title="YoungGL , JewellD . Interventions for leg cramps in pregnancy. Cochrane Database of Systematic Reviews2002, Issue 1. [DOI: 10.1002/14651858.CD000121] ">Young 2002</a>), a RCT in nonpregnant sufferers reported no significant decrease in cramp frequency (<a href="./references#CD005044-bbs2-0097" title="RoffeC , SillsS , CromeP , JonesP . Randomised, cross‐over, placebo controlled trial of magnesium citrate in the treatment of chronic persistent leg cramps. Medical Science Monitor2002;8(5):326‐30. ">Roffe 2002</a>). </p> </section> <section id="CD005044-sec-0018"> <h3 class="title" id="CD005044-sec-0018">Description of the intervention</h3> <p>Quinine and its derivatives, quinine sulphate, hydroquinine and its optical isomer quinidine have been commonly prescribed to prevent cramps ever since a series of uncontrolled studies reported their beneficial effects in the 1940s (<a href="./references#CD005044-bbs2-0052" title="GootnickA . Night cramps and quinine. Archives of Internal Medicine1943;71(4):555‐62. ">Gootnick 1943</a>; <a href="./references#CD005044-bbs2-0083" title="MossHK , HerrmannLG . The use of quinine for relief of night cramps in the extremities. Journal of the American Medical Association1940;115:1358‐9. ">Moss 1940</a>; <a href="./references#CD005044-bbs2-0086" title="NicholsonJH , FalkA . Night cramps in young men. New England Journal of Medicine1945;233:556‐9. ">Nicholson 1945</a>). Small groups of up to 30 people suffering from recurrent cramps were given quinine and the subjective outcome of no, partial or complete alleviation was reported on a case‐by‐case basis. In all three studies, the majority of participants reported improvement in their cramps, an effect that was reversed when the quinine was withdrawn. </p> <p>Quinine (C₂₀H₂₄N₂O₂: molecular weight = 324), is a white crystalline alkaloid powder obtained from the bark of the cinchona tree which is native to the Andes region of South America (<a href="./references#CD005044-bbs2-0064" title="KrishnaS , WhiteNJ . Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clinical Pharmacokinetics1996;30(4):263‐99. ">Krishna 1996</a>). It comprises two benzene rings, and a covalently‐bonded nitrogenous carbon chain. Almost insoluble in water, it dissolves readily in alcohol and other organic solvents, and is used in the form of a salt, most commonly the sulphate. It is well known for its use in malaria and has been commercially synthesised from coal tar since 1944. Tonic water contains between 40 and 80 mg quinine/L. Quinine is inexpensive, bitter to taste, has excellent bioavailability and is predominantly excreted by the liver (<a href="./references#CD005044-bbs2-0064" title="KrishnaS , WhiteNJ . Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clinical Pharmacokinetics1996;30(4):263‐99. ">Krishna 1996</a>) but also by the kidneys to varying extents (<a href="./references#CD005044-bbs2-0073" title="MartindaleW , WestcottW . In: MartindaleW , WestcottW editor(s). The Extra Pharmacopoeia. 1st Edition. London: Royal Pharmaceutical Society, 1996:474‐77. ">Martindale 1996</a>). </p> <p>Quinine may have potentially serious adverse effects including fatal hypersensitivity reactions, particularly quinine‐induced thrombocytopenia (<a href="./references#CD005044-bbs2-0036" title="BarrE , DouglasJF , HillCM . Recurrent acute hypersensitivity to quinine. BMJ1990;301(6747):323. ">Barr 1990</a>) which can occur idiosyncratically from the ingestion of even minimal amounts of quinine, such as are present in commercial tonic waters (<a href="./references#CD005044-bbs2-0098" title="SchneemannM . Quinine. In: AronsonJK editor(s). Meyler's Side Effects of Drugs. 15th Edition. New York: Elsevier Science, 2006:3002‐7. ">Schneemann 2006</a>). Other hypersensitivity reactions include angio‐oedema, disseminated intravascular coagulation, pancytopenia (<a href="./references#CD005044-bbs2-0069" title="MaguireRB , StroncekDF , CampbellAC . Recurrent pancytopenia, coagulopathy, and renal failure associated with multiple quinine‐dependent antibodies. Annals of Internal Medicine1993;119(3):215‐17. ">Maguire 1993</a>) and haemolytic uraemic syndrome (<a href="./references#CD005044-bbs2-0074" title="McDonaldSP , ShanahanEM , ThomasAC , RoxbyDJ , BeroukasD , BarbaraJA . Quinine‐induced hemolytic uremic syndrome. Clinical Nephrology1997;47(6):397‐400. ">McDonald 1997</a>). General and toxic reactions on the other hand are dose‐dependent and become common when plasma concentrations reach 10 mg/L (<a href="./references#CD005044-bbs2-0098" title="SchneemannM . Quinine. In: AronsonJK editor(s). Meyler's Side Effects of Drugs. 15th Edition. New York: Elsevier Science, 2006:3002‐7. ">Schneemann 2006</a>). </p> <p>The dose of quinine used for the prevention of muscle cramps (200 to 300 mg daily) is significantly less than that used for the treatment of malaria (600 mg every eight hours); hence dose‐related adverse events are less common. However, gastrointestinal upset, abdominal pain, tinnitus and vertigo may occur, especially at higher doses, and quinine‐induced hypoglycaemia and renal insufficiency are also reported (<a href="./references#CD005044-bbs2-0098" title="SchneemannM . Quinine. In: AronsonJK editor(s). Meyler's Side Effects of Drugs. 15th Edition. New York: Elsevier Science, 2006:3002‐7. ">Schneemann 2006</a>). 'Cinchonism' is a symptom complex often linked to chronic use of quinine and consists of nausea, vomiting, vertigo, visual disturbances, tinnitus and hearing impairment (<a href="./references#CD005044-bbs2-0037" title="BatemanDN , BlainPG , WoodhouseKW , RawlinsMD , DysonH , HeyworthR , et al. Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. Quarterly Journal of Medicine1985;54(214):125‐31. ">Bateman 1985</a>). Quinine can interfere with the conduction pathways in the heart giving rise to arrhythmias, especially in overdosage (<a href="./references#CD005044-bbs2-0099" title="WhiteNJ . Cardiotoxicity of antimalarial drugs. Lancet Infectious Diseases2007;7(8):549‐58. ">White 2007</a>). Acute intoxication (ingestion of 4 to 12 g quinine) can cause convulsions followed by coma; death from respiratory arrest often results with doses exceeding 8 g. Permanent blindness has been reported in those with plasma concentrations over 10 mg/L (<a href="./references#CD005044-bbs2-0095" title="PrasadRS , KodaliVR , KhuraijamGS , ChoM , TraversJP . Acute confusion and blindness from quinine toxicity. European Journal of Emergency Medicine2003;10(4):353‐6. ">Prasad 2003</a>). </p> <p>Serious adverse effects including fatalities reported to the US Food and Drug Administration (FDA) led to the withdrawal of quinine from over‐the‐counter use and subsequently for all indications other than uncomplicated falciparum malaria (<a href="./references#CD005044-bbs2-0045" title="Food , DrugAdministration . Advance notice of proposed rulemaking to reopen the rulemaking for OTC internal analgesic, antipyretic, and antirheumatic drug products. Federal Register Oct 1, 1982; Vol. Docket No: 47 FR 43562:Sec 330.10(a). ">FDA 1982</a>; <a href="./references#CD005044-bbs2-0046" title="Food , DrugAdministration . Drug Products for the Treatment and/or Prevention of Nocturnal Leg Muscle Cramps for Over‐the‐Counter Human Use; Final Rule. Federal Register, Docket No. 77N‐0094 Aug 22, 1994. ">FDA 1994</a>; <a href="./references#CD005044-bbs2-0047" title="Food , DrugAdministration . FDA orders stop to marketing of quinine for night leg cramps. FDA Homepage www.fda.gov (accessed 20 July 2008). ">FDA 1995a</a>; <a href="./references#CD005044-bbs2-0048" title="Food , DrugAdministration . Drug products containing quinine for the treatment and/or prevention of malaria for over‐the‐counter human use; proposed rule. Federal Register 19 April 1995;60:19649‐55. ">FDA 1995b</a>; <a href="./references#CD005044-bbs2-0049" title="Food , DrugAdministration . Quinine: important warning. www.fda.gov/bbs/topics/news/2006/new01521 12 December 2006 (accessed 20 July 2008). ">FDA 2006</a>). A recent report from the American Academy of Neurology has recommended that quinine should not be used for the routine treatment of cramps, but only in cases of severe cramp where other treatments have failed and there is careful monitoring of side effects (<a href="./references#CD005044-bbs2-0060" title="KatzbergHD , KhanAH , SoYT . Assessment: symptomatic treatment for muscle cramps (an evidence‐based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology2010;74(8):691–6. ">Katzberg 2010</a>). The FDA continue to be concerned about 'off label' use for nocturnal muscle cramp (<a href="http://www.fda.gov/ForHealthProfessionals/ArticlesofInterest/ucm317811.htm" target="_blank">www.fda.gov/ForHealthProfessionals/ArticlesofInterest/ucm317811.htm</a>). </p> </section> <section id="CD005044-sec-0019"> <h3 class="title" id="CD005044-sec-0019">How the intervention might work</h3> <p>The precise mechanism of action of quinine is not known but it is believed to have a similar effect to curare on muscles and the neuromuscular junction. Quinine increases the refractory period of muscle, thereby reducing its response to repetitive stimulation (<a href="./references#CD005044-bbs2-0051" title="GoodmanL , GilmanA . The Pharmacological Basis of Therapeutics. 10th Edition. New York: McGraw‐Hill, 2001. ">Goodman 2001</a>). It also reduces the excitability of the motor end plate so that there is a diminished response to nerve stimulation and acetylcholine (<a href="./references#CD005044-bbs2-0055" title="HarveyA . The mechanism of action of quinine in myotonia and myasthenia. JAMA1939;112:1562‐3. ">Harvey 1939</a>). </p> </section> <section id="CD005044-sec-0020"> <h3 class="title" id="CD005044-sec-0020">Why it is important to do this review</h3> <p>The first meta‐analysis of the efficacy of quinine for treating muscle cramps was published in 1995 and combined the results of six randomised, double‐blind, controlled trials investigating nocturnal leg cramps (<a href="./references#CD005044-bbs2-0070" title="Man‐Son‐HingM , WellsG . Meta‐analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people. BMJ1995;310(6971):13‐17. ">Man‐Son‐Hing 1995</a>). It concluded that treatment with quinine sulphate significantly reduced the number of cramps over a four‐week period by 8.83 (95% CI 4.2 to 13.5) cramps compared to placebo. However, the duration and intensity of individual cramps was not significantly affected by treatment. The same authors published a second meta‐analysis in 1998 that included three new unpublished trials which, when incorporated, decreased the magnitude of the reduction in the number of cramps to 3.6 (95% CI 2.2 to 5.1) fewer cramps than placebo (over four weeks) which remained significant (<a href="./references#CD005044-bbs2-0071" title="Man‐Son‐HingM , WellsG , LauA . Quinine for nocturnal leg cramps: a meta‐analysis including unpublished data. Journal of General Internal Medicine1998;13(9):600‐6. ">Man‐Son‐Hing 1998</a>). The reduction in individual cramp intensity became significant, but the change in cramp duration remained nonsignificant. New data have been generated since the meta‐analyses of Man‐Song‐Hing (<a href="./references#CD005044-bbs2-0070" title="Man‐Son‐HingM , WellsG . Meta‐analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people. BMJ1995;310(6971):13‐17. ">Man‐Son‐Hing 1995</a>; <a href="./references#CD005044-bbs2-0071" title="Man‐Son‐HingM , WellsG , LauA . Quinine for nocturnal leg cramps: a meta‐analysis including unpublished data. Journal of General Internal Medicine1998;13(9):600‐6. ">Man‐Son‐Hing 1998</a>). This systematic review includes these new studies. The review was first published in 2010 and this update in 2014. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005044-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005044-sec-0021"></div> <p>To assess the efficacy or safety of quinine‐based agents in treating muscle cramps.</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005044-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005044-sec-0022"></div> <section id="CD005044-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005044-sec-0024"> <h4 class="title">Types of studies</h4> <p>We included all randomised controlled trials (RCTs) and quasi‐RCTs of quinine‐based agents for muscle cramps. Both cross‐over and parallel study designs were accepted and studies did not have to be double‐blinded. We included studies comparing quinine to placebo or to any other medication. </p> </section> <section id="CD005044-sec-0025"> <h4 class="title">Types of participants</h4> <p>We included results from participants of all ages who suffered muscle cramps from any cause and in any setting. There is no universally accepted definition for muscle cramp and studies vary greatly in their diagnostic criteria. We defined a muscle cramp as a sudden, intense involuntary contraction of a muscle during rest or activity, accompanied by visible or palpable muscle hardening and pain. We included cramps in any body part, occurring at any time of day or night, and of any frequency. </p> </section> <section id="CD005044-sec-0026"> <h4 class="title">Types of interventions</h4> <p>We included all the salts and derivatives of quinine such as quinine sulphate, quinine bisulphate, hydroquinine, hydroquinine hydrobromide and quinidine, the optical isomer of quinine. We excluded trials that did not contain a treatment arm solely composed of a quinine salt, as combinations with non‐quinine‐based drugs would mean the resultant effect could not be ascribed solely to the quinine component of the intervention. All doses and timing regimens of quinine administration were accepted. </p> </section> <section id="CD005044-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD005044-sec-0028"> <h5 class="title">Primary outcomes</h5> <p>Absolute difference in number of cramps (occurring day or night) during a two‐week treatment period. </p> <p>The number of cramps was selected as the primary outcome on the grounds that it is the most commonly used outcome in clinical trials. For trials that involved treatment periods greater than two weeks, the results were standardised to provide comparable data for combined analysis at two weeks. For example, studies with treatment periods of four weeks had the reported number of cramps divided by two. </p> </section> <section id="CD005044-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD005044-list-0001"> <li> <p>Difference in cramp intensity; there are a variety of 'pain scales' and so these were standardised to a three‐point scale (1 = mild, 2 = moderate, 3 = severe) to allow the results to be combined. This was done by scaling the scores proportionately (for example with a scale of 1 to 10, the score was divided by 3.33). </p> </li> <li> <p>Difference in cramp duration (in minutes per cramp).</p> </li> <li> <p>Absolute difference in number of 'cramp days' during a two‐week treatment period. This was the number of days in which the person suffered one or more cramps. </p> </li> <li> <p>Participants with one or more minor adverse events. A 'minor' adverse event was defined as a reported side effect not severe enough to require withdrawal of treatment (e.g. diarrhoea or constipation). </p> </li> <li> <p>Participants with one or more serious adverse events. A 'major' adverse event was defined as a side effect severe enough to require withdrawal of treatment (e.g. pancytopenia). </p> </li> </ol> </p> </section> </section> </section> <section id="CD005044-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD005044-sec-0031"> <h4 class="title">Electronic searches</h4> <p>With the assistance of the Cochrane Neuromuscular Disease Group, we searched the Cochrane Neuromuscular Disease Group Specialized Register (27 October 2014), CENTRAL (2014, Issue 9 in <i>The Cochrane Library</i>), MEDLINE (January 1966 to October 2014) and EMBASE (January 1980 to October 2014). The detailed search strategies are in the appendices: <a href="./appendices#CD005044-sec-0105">Appendix 1</a> (MEDLINE), <a href="./appendices#CD005044-sec-0106">Appendix 2</a> (EMBASE), <a href="./appendices#CD005044-sec-0107">Appendix 3</a> (Cochrane Neuromuscular Disease Group Specialized Register) and <a href="./appendices#CD005044-sec-0108">Appendix 4</a> (CENTRAL). </p> <p>On 3 November 2014 we also searched trial registries, ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov/</a>) and World Health Organization International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>) for ongoing trials (<a href="./appendices#CD005044-sec-0109">Appendix 5</a>). </p> </section> <section id="CD005044-sec-0032"> <h4 class="title">Searching other resources</h4> <p>We contacted the American and British drug regulatory agencies and relevant pharmaceutical companies that manufacture quinine products to request any unpublished trials in their possession. We also contacted the authors of relevant trials and reviews to identify additional published or unpublished data. We checked the reference lists of these papers for further relevant material. </p> </section> </section> <section id="CD005044-sec-0033"> <h3 class="title" id="CD005044-sec-0033">Data collection and analysis</h3> <section id="CD005044-sec-0034"> <h4 class="title">Selection of studies</h4> <p>For the original review, three review authors independently checked the titles and abstracts of the articles identified by the search, obtaining the full text of all potentially relevant studies. The review authors selected the trials that satisfied the inclusion criteria for the review and graded their risk of bias and extracted data onto specially designed forms. There were no disagreements on which trials were to be excluded. For the update two authors (RB and SET) independently checked the titles and abstracts from the literature searches. </p> </section> <section id="CD005044-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>Four authors (SET, TAM, HV and TET) were involved in the data extraction, its checking and analysis. Three review authors independently extracted the data relating to the primary and secondary outcomes for all the included trials, and a fourth checked them. </p> <p>One review author (SET) transferred study characteristics and outcome data into the Cochrane authoring and statistical software Review Manager (<a href="./references#CD005044-bbs2-0096" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and a second author (TAM) carried out checks. </p> <p>We transformed outcome data as described in <a href="#CD005044-sec-0027">Types of outcome measures</a> to standardise reporting. </p> </section> <section id="CD005044-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Three review authors assessed the risk of bias of the trials independently using the recommended approach described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005044-bbs2-0058" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). This addresses six specific domains: adequate sequence generation; allocation concealment; blinding; incomplete outcome data; selective outcome reporting; and 'other sources of bias'. We gave each trial a classification of 'low risk', 'high risk' or 'unclear risk' (i.e. insufficient or no information). A fourth author resolved disagreements. </p> </section> <section id="CD005044-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>We combined the results of trials identified for inclusion in this review, where possible, using the Cochrane statistical package, RevMan. We combined continuous outcomes using the generic inverse variance (GIV) method which allows paired data from cross‐over trials (where each participant acts as their own control) to be combined with the results of two‐group parallel studies, producing a mean treatment effect with a 95% confidence interval (CI). For dichotomous outcomes (presence of major or minor adverse events), we calculated risk differences (RDs) with 95% CIs. </p> </section> <section id="CD005044-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>As noted above, we used GIV analysis to allow combination of parallel‐group and cross‐over studies. If multiple trial arms had been reported in a single trial, we would have included only the relevant arms. </p> </section> <section id="CD005044-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>Where possible we derived standard errors (SE) from other data in order to perform GIV analyses. We contacted authors for missing data, but where we received no reply, we used the data within the studies to derive a standard error which could be used in the meta analysis. </p> </section> <section id="CD005044-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>We asssessed heterogeneity using the I<sup>2</sup> statistic (<a href="./references#CD005044-bbs2-0057" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). Where we identified substantial unexplained heterogeneity, we reported it and explored possible causes by sensitivity analysis. </p> </section> <section id="CD005044-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>Not done</p> </section> <section id="CD005044-sec-0042"> <h4 class="title">Data synthesis</h4> <p>We undertook a fixed‐effect analysis initially and where the I² statistic exceeded 25%, undertook a sensitivity analysis. If heterogeneity remained unexplained, we used the random‐effects model of analysis. We regarded any outcome with a P value below 0.05 as significant. We also expressed all outcomes that reached statistical significance as relative percentage differences. </p> <p>We discussed the adverse effects of quinine in the light of the results of this meta‐analysis. We used other sources of information for quinine's adverse event profile, including studies that were not randomised and texts such as <i>Meyler's Adverse Events of Drugs</i> (<a href="./references#CD005044-bbs2-0098" title="SchneemannM . Quinine. In: AronsonJK editor(s). Meyler's Side Effects of Drugs. 15th Edition. New York: Elsevier Science, 2006:3002‐7. ">Schneemann 2006</a>). We also discussed the costs and cost‐benefits of treating muscle cramp with quinine. </p> <p>We created a 'Summary of findings' tables for comparisons where more than one trial was available. We presented the following outcomes: </p> <p> <ul id="CD005044-list-0002"> <li> <p>Number of cramps over two weeks</p> </li> <li> <p>Cramp intensity</p> </li> <li> <p>Participants suffering major adverse events</p> </li> <li> <p>Participants suffering minor adverse events</p> </li> </ul> </p> <p>We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of a body of evidence (studies that contribute data for the prespecified outcomes). We used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005044-bbs2-0058" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) using GRADEpro software. We justified all decisions to down‐ or up‐grade the quality of studies using footnotes and we made comments to aid readers' understanding of the review where necessary. </p> </section> <section id="CD005044-sec-0043"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>For the quinine versus placebo comparison and the outcome cramp number, we conducted a subgroup analysis by quinine dose. This was not a pre‐specified analysis. </p> </section> <section id="CD005044-sec-0044"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out a sensitivity analysis when I<sup>2</sup> exceeded 25% by excluding: </p> <p> <ul id="CD005044-list-0003"> <li> <p>trials that on examination had obvious potential sources of heterogeneity</p> </li> <li> <p>trials at a high or unclear risk of bias for adequate sequence generation, allocation concealment, and blinding </p> </li> </ul> </p> <p>We have described any deviations from the published protocol (<a href="./references#CD005044-bbs2-0103" title="El‐TawilS , MusaTA , El‐TawilT , WeberM . Quinine for muscle cramps. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD005044] ">El Tawil 2004</a>) in <a href="#CD005044-sec-0117">Differences between protocol and review</a>. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005044-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005044-sec-0045"></div> <section id="CD005044-sec-0046"> <h3 class="title">Description of studies</h3> <p>The new, updated searches produced the following results: Cochrane Neuromuscular Disease (NMD) Group Specialized Register 32 papers, MEDLINE 186 papers, EMBASE 89 papers and CENTRAL 42 papers. There were no new studies satisfying our inclusion criteria. Searches of the trials registries ClinicalTrials.gov and ICTRP revealed no ongoing trials. </p> <p>For the original review, search results from MEDLINE, EMBASE, CENTRAL and the Cochrane NMD Group Register revealed 259, 171, 43 and 22 papers, respectively. One hundred and twenty‐six titles were relevant to the topic and the abstracts of these were analysed. The authors reviewed the full texts of 28 studies. They eliminated five (see <a href="./references#CD005044-bbs1-0002" title="">Excluded studies</a>) leaving 23 studies that fulfilled our inclusion criteria. Quinine was compared to placebo (20 trials), to vitamin E (four trials), to a combination of quinine and vitamin E (also known as Q‐Vel) (three trials), to a combination of quinine and theophylline (one trial; <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>) and to xylocaine injections (one trial; <a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a>). Four trials compared quinine to more than one treatment (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>; <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>). See <a href="#CD005044-tbl-0004">Table 1</a> for a tabulated summary of the trials and <a href="./references#CD005044-bbs1-0001" title="">Included studies</a> for further detail. </p> <div class="table" id="CD005044-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study design of the 23 included trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of participants</b> </p> <p><b>Study design</b> </p> <p><b>Patient focus</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> <p><b>age (yrs)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Female</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Male</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>F: M ratio</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quinine</b> </p> <p><b>dose (mg)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment</b> </p> <p><b>period (d)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Washout period (d)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Treatment comparisons</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 24</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quinine‐vitamin E combination (Q‐Vel<sup>®</sup>)<sup>b</sup> ✓ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0002" title="BottnerM (for Scholl Inc.) . Clinical trial of the efficacy of quinine sulphate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">Bottner 1984</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 69</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 556</p> <p>Study design = P</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> <p>Vitamin E ✓</p> <p>Quinine‐vitamin E combination (Q‐Vel<sup>®)</sup> ✓ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 30</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> <p>Vitamin E ✓<sup>c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0006" title="DunnNR . Effectiveness of quinine for night cramps. British Journal of General Practice1993;43(368):127‐8. [PUBMED: 8323792] ">Dunn 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 28</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0005" title="DienerHC , DethlefsenU , Dethlefsen‐GruberS , VerbeekP . Effectiveness of quinine in treating muscle cramps: a double‐blind, placebo‐controlled, parallel‐group, multicentre trial. International Journal of Clinical Practice2002;56(4):243‐6. [PUBMED: 12074203] ">Diener 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 94</p> <p>Study design = P</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0007" title="FungMC , HolbrookJH . Placebo‐controlled trial of quinine therapy for nocturnal leg cramps. Western Journal of Medicine1989;151(1):42‐4. [PUBMED: 2669346] ">Fung 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 9</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 164</p> <p>Study design = P</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> <p>Quinine‐theophylline combination (Limptar<sup>®</sup>)<sup>b</sup> ✓ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0009" title="HaysRM , Goodman JJ (for SchollInc.) . Clinical trial of the efficacy of quinine sulfate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Hays 1986</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 62</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0010" title="JansenPH , VeenhuizenKC , VerbeekAL , StraatmanH . Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. Journal of the Neurological Sciences1994;122(2):157‐61. [PUBMED: 8021700] ">Jansen 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 20</p> <p>Study design = P<br/> Patient focus = I </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 106</p> <p>Study design = P</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0012" title="JonesK , CastledenCM . A double‐blind comparison of quinine sulphate and placebo in muscle cramps. Age and Ageing1983;12(2):155‐8. [PUBMED: 6346830] ">Jones 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 9</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 9</p> <p>Study design = C</p> <p>Patient focus = H</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>320<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 31</p> <p>Study design = P</p> <p>Patient focus = L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 205</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> <p>Vitamin E ✓</p> <p>Quinine‐vitamin E combination (Q‐Vel<sup>®</sup>) ✓ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0016" title="LimSH . Randomised double‐blind trial of quinine sulphate for nocturnal leg cramp. British Journal of Clinical Practice1986;40(11):462. [PUBMED: 3307858] ">Lim 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 25</p> <p>Study design = P</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≤ 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 16</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 24</p> <p>Study design = P</p> <p>Patient focus = I<sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Xylocaine injection ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 30</p> <p>Study design = P</p> <p>Patient focus = H</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60<sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin E ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0020" title="SidorovJ . Quinine sulfate for leg cramps: does it work?. Journal of the American Geriatrics Society1993;41(5):498‐500. [PUBMED: 8486881] ">Sidorov 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 19</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 21</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 22</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 13</p> <p>Study design = N‐of‐1</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200 to 300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: C: cross‐over, P: parallel, H: haemodialysis‐induced cramps, I: idiopathic, L: patients with liver cirrhosis; n/a: not available </p> <p><sup>a</sup>Unpublished.<br/> <sup>b</sup>Q‐Vel<sup>®</sup>: trade name for quinine‐vitamin E combination; Limptar<sup>®</sup>:trade name for quinine‐theophylline combination.<br/> <sup>c</sup><a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> did not directly compare quinine versus vitamin E ‐ using the data provided we were able to draw comparison.<br/> <sup>d</sup>Quinine dose given at beginning of each dialysis session (3 times per wk) and not daily.<br/> <sup>e</sup>Inclusion criteria included presence of myofascial trigger point in gastrocnemius.<br/> <sup>f</sup>A 60‐day trial but results only reported from first month of treatment. </p> </div> </div> <p>Thirteen trials were cross‐over in design, nine were parallel studies, and one was a 'N‐of‐1' trial (see <a href="#CD005044-tbl-0004">Table 1</a>). The 23 studies involved a total of 1586 unique participants commencing the trials; 523 were from cross‐over trials and thus formed their own controls. The number of participants in each trial varied from 9 to 556, with only four trials containing more than 100 participants. Of the 23 trials included, five were unpublished studies acquired via the United States Food and Drug Administration (FDA). Indeed, the two largest trials included in this meta‐analysis were both large unpublished multicentre studies conducted by pharmaceutical companies in the United States: <a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a> with 556 participants, and <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a> with 205 participants. The five unpublished studies contributed 58% of the total number of participants included in this meta‐analysis. The third largest trial was translated from German (<a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>). This was the only trial to compare quinine with a combination of quinine and theophylline, and was also conducted by a pharmaceutical company. </p> <p>Twenty trials investigated idiopathic muscle cramps, most often in elderly participants suffering from nocturnal leg cramps. In one (<a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a>), inclusion criteria included nocturnal calf cramps associated with a demonstrable myofascial trigger point on the medial head of the gastrocnemius muscle. Two studies (<a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>; <a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>) recruited only participants who suffered haemodialysis‐related cramps, whilst one study (<a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>) recruited those with liver cirrhosis. The participants were all outpatients from general practice and medical clinics, except those in one trial (<a href="./references#CD005044-bbs2-0016" title="LimSH . Randomised double‐blind trial of quinine sulphate for nocturnal leg cramp. British Journal of Clinical Practice1986;40(11):462. [PUBMED: 3307858] ">Lim 1986</a>) who were inpatients on a general medical ward. </p> <p>The typical format of the cross‐over trials consisted of an initial 'run‐in period' of around two weeks, allowing baseline characteristics to be assessed, inclusion criteria to be met, and any quinine from previous treatment to be washed out. Common inclusion criteria were: minimum cramp frequency of two per week, and the absence of conditions predisposing to cramps in those trials investigating idiopathic cramps. Common exclusion criteria included: electrolyte disturbances, renal or hepatic impairment, detectable quinine serum levels after the run‐in phase, and the use of concomitant medication interfering with quinine or cramp sensation. Time periods for trial washout and cross‐over varied. The washout interval ranged from 0 days (<a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>; <a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a>; <a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a>; <a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a>) to 28 days (<a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>) (see <a href="#CD005044-tbl-0004">Table 1</a>). Parallel group trials included a follow‐up assessment period. </p> <p>The average age of the population under investigation in each study varied from 44 to 76 years (mean of these averages = 58 years). The youngest affected with cramp was 17 years and the oldest 87 years. Of the 19 trials that included gender demographics, 15 had a female preponderance, 11 of which contained more than twice as many women as men. The mean female to male ratio across the 19 trials describing sex distribution was 3.8. Of the four trials containing more men than women, one was conducted at a Veterans Affairs medical centre (<a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>; 100% men), and another investigated people with liver cirrhosis resulting from chronic hepatitis and not alcohol intake (<a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>; 84% men). </p> <p>Twenty trials used the sulphate salt of quinine as the active treatment, two studies (<a href="./references#CD005044-bbs2-0010" title="JansenPH , VeenhuizenKC , VerbeekAL , StraatmanH . Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. Journal of the Neurological Sciences1994;122(2):157‐61. [PUBMED: 8021700] ">Jansen 1994</a>; <a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a>) used hydroquinine hydrobromide, and one trial (<a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>) used the quinine isomer quinidine. Most of the trials used a daily quinine dose of 300 mg, closely followed by 200 mg. Two trials (<a href="./references#CD005044-bbs2-0005" title="DienerHC , DethlefsenU , Dethlefsen‐GruberS , VerbeekP . Effectiveness of quinine in treating muscle cramps: a double‐blind, placebo‐controlled, parallel‐group, multicentre trial. International Journal of Clinical Practice2002;56(4):243‐6. [PUBMED: 12074203] ">Diener 2002</a>: <a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>) used doses of 400 mg, and one trial (<a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>) used a dose of 500 mg. The <a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a> trial maintained participants on the dosage of quinine which they had previously been prescribed (mainly 200 mg). </p> <p>The duration of treatment with quinine ranged from five days (<a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>) to 42 days (<a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>; <a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a>), with the majority (10 trials) treating for 14 days. One trial administered active medication for 60 days but only provided results for the first month of treatment (<a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>). The <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a> trial compared four treatments in cross‐over design over four weeks and so the treatment duration was limited to five days each with only two days washout in between treatments. A poorly designed trial treated patients on a general medical ward up to their discharge date or for up to two weeks, whichever was shorter (<a href="./references#CD005044-bbs2-0016" title="LimSH . Randomised double‐blind trial of quinine sulphate for nocturnal leg cramp. British Journal of Clinical Practice1986;40(11):462. [PUBMED: 3307858] ">Lim 1986</a>). </p> <p>The timing of drug administration varied between trials; the majority of studies advised participants to take the therapy at or approaching bedtime, while the others divided the dose across the evening (<a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>) or in a morning/evening regimen (<a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>). Of the two haemodialysis trials, one (<a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>) administered quinine or placebo at the beginning of each dialysis session only (three times per week), whilst the other (<a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>) administered the study drug daily. The parallel trial involving xylocaine injections (<a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a>) gave one group daily 300 mg quinine at bedtime and the other group an injection of 1% xylocaine into the medial head of the gastrocnemius muscle at the start of the four‐week treatment period. Symptoms were reviewed on a fortnightly basis and further injections administered depending on the frequency of any ongoing symptoms. </p> <p>Cramp number was the most common outcome measured in the trials. Some trials combined the cramp intensity with duration to give a 'cramp index' which was not an outcome in this meta‐analysis. All but two trials recorded adverse events as an outcome (<a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>; <a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a>). In <a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>, the frequency and severity of cramps was assessed only during dialysis sessions and not between them. </p> </section> <section id="CD005044-sec-0047"> <h3 class="title">Risk of bias in included studies</h3> <p>The 'Risk of bias' assessment was performed as set out in the <a href="#CD005044-sec-0022">Methods</a>. </p> <p>The quality of the trials varied considerably. Newer trials were of better design, incorporating more appropriate statistical analysis, applying intention‐to‐treat analysis and taking into consideration baseline differences. The unpublished studies in general were much more detailed, each comprising several documents, and were conducted by professional pharmaceutical investigators. </p> <p>All 23 trials claimed to be randomised, but only eight actually described the method of randomisation (<a href="./references#CD005044-sec-0119" title="">Characteristics of included studies</a>; <a href="#CD005044-fig-0001">Figure 1</a>). Likewise, only eight trials stated how allocation was concealed. </p> <div class="figure" id="CD005044-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study. Red = high risk of bias; yellow = unclear risk of bias; green = low risk of bias." data-id="CD005044-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. Red = high risk of bias; yellow = unclear risk of bias; green = low risk of bias. </p> </div> </div> </div> <p>Fourteen studies were judged to be adequately double‐blinded (<a href="#CD005044-fig-0001">Figure 1</a>). There was insufficient information to pass judgement in four trials, whilst five trials were not double‐blinded: quinine and placebo tablets looked different in one trial (<a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a>), tasted different in two trials (<a href="./references#CD005044-bbs2-0010" title="JansenPH , VeenhuizenKC , VerbeekAL , StraatmanH . Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. Journal of the Neurological Sciences1994;122(2):157‐61. [PUBMED: 8021700] ">Jansen 1994</a>; <a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a>), physicians were not blinded in another (<a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>), and both participant and observer were aware of the treatments administered (xylocaine injections or oral quinine) in another (<a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a>). </p> <p>Thirteen studies were considered to have adequately addressed any incomplete outcome data. Two studies did not give complete details for participant withdrawal (<a href="./references#CD005044-bbs2-0006" title="DunnNR . Effectiveness of quinine for night cramps. British Journal of General Practice1993;43(368):127‐8. [PUBMED: 8323792] ">Dunn 1993</a>; <a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a>) and two did not mention the drop‐outs at all (<a href="./references#CD005044-bbs2-0002" title="BottnerM (for Scholl Inc.) . Clinical trial of the efficacy of quinine sulphate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">Bottner 1984</a>; <a href="./references#CD005044-bbs2-0005" title="DienerHC , DethlefsenU , Dethlefsen‐GruberS , VerbeekP . Effectiveness of quinine in treating muscle cramps: a double‐blind, placebo‐controlled, parallel‐group, multicentre trial. International Journal of Clinical Practice2002;56(4):243‐6. [PUBMED: 12074203] ">Diener 2002</a>). In the <a href="./references#CD005044-bbs2-0002" title="BottnerM (for Scholl Inc.) . Clinical trial of the efficacy of quinine sulphate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">Bottner 1984</a> trial, 15 drop‐outs were unaccounted for and one suffered quinine‐related adverse events and was not followed up. One study did not give the number of participants completing the trial (<a href="./references#CD005044-bbs2-0016" title="LimSH . Randomised double‐blind trial of quinine sulphate for nocturnal leg cramp. British Journal of Clinical Practice1986;40(11):462. [PUBMED: 3307858] ">Lim 1986</a>). Intention‐to‐treat analysis was not used in six studies (<a href="./references#CD005044-bbs2-0007" title="FungMC , HolbrookJH . Placebo‐controlled trial of quinine therapy for nocturnal leg cramps. Western Journal of Medicine1989;151(1):42‐4. [PUBMED: 2669346] ">Fung 1989</a>; <a href="./references#CD005044-bbs2-0010" title="JansenPH , VeenhuizenKC , VerbeekAL , StraatmanH . Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. Journal of the Neurological Sciences1994;122(2):157‐61. [PUBMED: 8021700] ">Jansen 1994</a>; <a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a>; <a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a>; <a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>; <a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a>). </p> <p>The majority of studies were free of selective reporting (<a href="#CD005044-fig-0001">Figure 1</a>), but five studies did not report on their adverse event outcomes (<a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>; <a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a>) or other outcomes stipulated in their methods (<a href="./references#CD005044-bbs2-0010" title="JansenPH , VeenhuizenKC , VerbeekAL , StraatmanH . Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. Journal of the Neurological Sciences1994;122(2):157‐61. [PUBMED: 8021700] ">Jansen 1994</a>; <a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a>; <a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>). </p> <p>Other sources of bias included the lack of sufficient washout periods in cross‐over treatments (<a href="./references#CD005044-bbs2-0006" title="DunnNR . Effectiveness of quinine for night cramps. British Journal of General Practice1993;43(368):127‐8. [PUBMED: 8323792] ">Dunn 1993</a>; <a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>; <a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a>; <a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a>; <a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a>), the fact that six studies were conducted by pharmaceutical companies (<a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a>; <a href="./references#CD005044-bbs2-0002" title="BottnerM (for Scholl Inc.) . Clinical trial of the efficacy of quinine sulphate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">Bottner 1984</a>; <a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>; <a href="./references#CD005044-bbs2-0009" title="HaysRM , Goodman JJ (for SchollInc.) . Clinical trial of the efficacy of quinine sulfate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Hays 1986</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>) (although this is not always considered a source of significant bias), gender bias (<a href="./references#CD005044-bbs2-0002" title="BottnerM (for Scholl Inc.) . Clinical trial of the efficacy of quinine sulphate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">Bottner 1984</a>; <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>; <a href="./references#CD005044-bbs2-0007" title="FungMC , HolbrookJH . Placebo‐controlled trial of quinine therapy for nocturnal leg cramps. Western Journal of Medicine1989;151(1):42‐4. [PUBMED: 2669346] ">Fung 1989</a>; <a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>; <a href="./references#CD005044-bbs2-0010" title="JansenPH , VeenhuizenKC , VerbeekAL , StraatmanH . Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. Journal of the Neurological Sciences1994;122(2):157‐61. [PUBMED: 8021700] ">Jansen 1994</a>; <a href="./references#CD005044-bbs2-0020" title="SidorovJ . Quinine sulfate for leg cramps: does it work?. Journal of the American Geriatrics Society1993;41(5):498‐500. [PUBMED: 8486881] ">Sidorov 1993</a>), and intra‐study variability in treatment dose (<a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a>; <a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a>) or duration (<a href="./references#CD005044-bbs2-0016" title="LimSH . Randomised double‐blind trial of quinine sulphate for nocturnal leg cramp. British Journal of Clinical Practice1986;40(11):462. [PUBMED: 3307858] ">Lim 1986</a>). </p> <p>Not all data could be entered into the meta‐analysis. Two trials did not contain sufficient data for entry into the meta‐analysis (<a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a>; <a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a>). The <a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a> trial did not include any washout period between quinine and placebo and no data were given for the results. The <a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a> trial failed to give any detail on the cramp number outcome, whilst the information on adverse events could not be ascribed to a set number of participants. </p> <p>The only data that could be entered from three of the trials were those of the adverse events experienced (<a href="./references#CD005044-bbs2-0002" title="BottnerM (for Scholl Inc.) . Clinical trial of the efficacy of quinine sulphate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">Bottner 1984</a>; <a href="./references#CD005044-bbs2-0016" title="LimSH . Randomised double‐blind trial of quinine sulphate for nocturnal leg cramp. British Journal of Clinical Practice1986;40(11):462. [PUBMED: 3307858] ">Lim 1986</a>; <a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>). <a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a> measured the number of cramps during dialysis sessions only and not over 24 hours, and this outcome was thus excluded from the meta‐analysis.The <a href="./references#CD005044-bbs2-0016" title="LimSH . Randomised double‐blind trial of quinine sulphate for nocturnal leg cramp. British Journal of Clinical Practice1986;40(11):462. [PUBMED: 3307858] ">Lim 1986</a> trial presented very basic information on design and conduct. The trial did not have a set treatment duration and also failed to specify how many participants were randomised to each group. The results were not reported fully and carried no measure of spread. The GIV method of meta‐analysis is dependent upon the calculation of a standard error (SE) from standard deviations (SDs); where SDs were not available, the SE was approximated from a range, or CI, or from measures of significance (P values). None of these were available for the <a href="./references#CD005044-bbs2-0002" title="BottnerM (for Scholl Inc.) . Clinical trial of the efficacy of quinine sulphate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">Bottner 1984</a> trial and so the results could not be entered into the meta‐analysis. </p> </section> <section id="CD005044-sec-0048"> <h3 class="title" id="CD005044-sec-0048">Effects of interventions</h3> <p>See: <a href="./full#CD005044-tbl-0001"><b>Summary of findings for the main comparison</b> Quinine versus placebo for muscle cramps</a>; <a href="./full#CD005044-tbl-0002"><b>Summary of findings 2</b> Quinine versus vitamin E for muscle cramps</a>; <a href="./full#CD005044-tbl-0003"><b>Summary of findings 3</b> Quinine versus a quinine‐vitamin E combination (Q‐Vel) for muscle cramps</a> </p> <section id="CD005044-sec-0049"> <h4 class="title">Quinine versus placebo</h4> <section id="CD005044-sec-0050"> <h5 class="title">Primary outcome measure: difference in number of cramps (occurring day or night) during a two‐week treatment period </h5> <p>Eighteen placebo‐controlled trials reported the absolute number of cramps occurring over their study period. To allow the results to be combined in a meta‐analysis, we standardised the data to the number of cramps occurring over <i>two</i> weeks. </p> <p>Four trials could not be entered into the meta‐analysis for the reasons given above (<a href="./references#CD005044-bbs2-0002" title="BottnerM (for Scholl Inc.) . Clinical trial of the efficacy of quinine sulphate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">Bottner 1984</a>; <a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>; <a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a>; <a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a>). The 14 trials (n = 982) entered into the meta‐analysis all investigated idiopathic muscle cramps except one (<a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>), which investigated cramps in people with liver cirrhosis. The results of the <a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a> trial were comparable with the rest. When the 14 trials were entered into the meta‐analysis, the combined mean change in the number of cramps was ‐1.81 (95% CI ‐2.20 to ‐1.42) (See <a href="./references#CD005044-fig-0009" title="">Analysis 1.1</a>). </p> <p>Significant heterogeneity was detected in the meta‐analysis (I² = 89%). Inspection of the included trials identified potential causes in two trials. The small trial of <a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a> contained large standard errors for the primary outcome and <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> was the only trial to use 500 mg quinine and included only men. The exclusion of <a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a> did not reduce the heterogeneity but excluding <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> reduced the I² index to 71%. We performed further sensitivity analyses excluding all trials at a high or unclear risk of bias for adequate sequence generation, allocation concealment, and blinding; the heterogeneity index changed to 50%, 67% and 91% respectively. Quinine remained significantly effective compared to placebo in all these sensitivity analyses. After discussion, we excluded <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> only because of its unique participant selection and quinine dose, and used a random‐effects model. Quinine resulted in a significant decrease in cramp number (‐2.45 cramps, 95% CI ‐3.54 to ‐1.36, random‐effects), equivalent to a 28% (95% CI 15% to 40%) reduction over placebo (see <a href="./references#CD005044-fig-0010" title="">Analysis 1.2</a>, <a href="#CD005044-fig-0002">Figure 2</a>). It is worth noting the persistent heterogeneity (I² = 71%) associated with this result. </p> <div class="figure" id="CD005044-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.2 Difference in number of cramps over 2 weeks ‐ random‐effects (minus Connolly 1992)." data-id="CD005044-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.2 Difference in number of cramps over 2 weeks ‐ random‐effects (minus Connolly 1992). </p> </div> </div> </div> <section id="CD005044-sec-0051"> <h6 class="title">Subgroup analysis according to quinine dose</h6> <p>We analysed the data for the effect of quinine dose on cramp number over two weeks (see <a href="./references#CD005044-fig-0011" title="">Analysis 1.3</a>), grouping the studies according to the dose of quinine used. Although there seems to be an increasing effect with dose from 300 mg through 400 mg to 500 mg, the 200 mg and 260 mg doses go against this trend. It is notable that the reduction in cramp number reported by using the higher 500 mg dose (<a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>) is more than double that achieved by any of the other doses. However, analysis of these data is severely undermined by the shortage of studies in each dose range; any conclusions drawn from these data would be highly speculative. </p> </section> </section> <section id="CD005044-sec-0052"> <h5 class="title">Change in cramp intensity during treatment period</h5> <p>Cramp intensity was reported in 13 of the 20 placebo‐controlled trials. A further two trials measured cramp intensity but combined it with duration to give an 'index' from which intensity itself could not be derived (<a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a>; <a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a>). </p> <p>From the 13 trials reporting intensity as an outcome, six trials could not be entered into the meta‐analysis. Three trials failed to report exact data (<a href="./references#CD005044-bbs2-0005" title="DienerHC , DethlefsenU , Dethlefsen‐GruberS , VerbeekP . Effectiveness of quinine in treating muscle cramps: a double‐blind, placebo‐controlled, parallel‐group, multicentre trial. International Journal of Clinical Practice2002;56(4):243‐6. [PUBMED: 12074203] ">Diener 2002</a>; <a href="./references#CD005044-bbs2-0010" title="JansenPH , VeenhuizenKC , VerbeekAL , StraatmanH . Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. Journal of the Neurological Sciences1994;122(2):157‐61. [PUBMED: 8021700] ">Jansen 1994</a>; <a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a>), standard errors could not be derived from two trials (<a href="./references#CD005044-bbs2-0002" title="BottnerM (for Scholl Inc.) . Clinical trial of the efficacy of quinine sulphate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">Bottner 1984</a>; <a href="./references#CD005044-bbs2-0016" title="LimSH . Randomised double‐blind trial of quinine sulphate for nocturnal leg cramp. British Journal of Clinical Practice1986;40(11):462. [PUBMED: 3307858] ">Lim 1986</a>), and one trial (<a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>) measured only the most severe cramp experienced each night. </p> <p>The remaining seven trials (n = 666) measured the intensity per cramp on different scales and so these were standardised to a three‐point scale (1 = mild pain, 2 = moderate pain, 3 = severe pain). Meta‐analysis of these trials (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0007" title="FungMC , HolbrookJH . Placebo‐controlled trial of quinine therapy for nocturnal leg cramps. Western Journal of Medicine1989;151(1):42‐4. [PUBMED: 2669346] ">Fung 1989</a>; <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>; <a href="./references#CD005044-bbs2-0009" title="HaysRM , Goodman JJ (for SchollInc.) . Clinical trial of the efficacy of quinine sulfate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Hays 1986</a>; <a href="./references#CD005044-bbs2-0012" title="JonesK , CastledenCM . A double‐blind comparison of quinine sulphate and placebo in muscle cramps. Age and Ageing1983;12(2):155‐8. [PUBMED: 6346830] ">Jones 1983</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>; <a href="./references#CD005044-bbs2-0020" title="SidorovJ . Quinine sulfate for leg cramps: does it work?. Journal of the American Geriatrics Society1993;41(5):498‐500. [PUBMED: 8486881] ">Sidorov 1993</a>) demonstrated that quinine was significantly better than placebo in reducing cramp intensity (‐0.12 units, 95% CI ‐0.20 to ‐0.05), representing a 10% drop (95% CI 4% to 16%) compared to placebo (<a href="./references#CD005044-fig-0012" title="">Analysis 1.4</a>). There was no heterogeneity in this meta‐analysis (I² = 0). </p> </section> <section id="CD005044-sec-0053"> <h5 class="title">Change in cramp duration (in minutes)</h5> <p>This was an outcome in eight of the trials (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0007" title="FungMC , HolbrookJH . Placebo‐controlled trial of quinine therapy for nocturnal leg cramps. Western Journal of Medicine1989;151(1):42‐4. [PUBMED: 2669346] ">Fung 1989</a>; <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>; <a href="./references#CD005044-bbs2-0010" title="JansenPH , VeenhuizenKC , VerbeekAL , StraatmanH . Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. Journal of the Neurological Sciences1994;122(2):157‐61. [PUBMED: 8021700] ">Jansen 1994</a>; <a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a>; <a href="./references#CD005044-bbs2-0012" title="JonesK , CastledenCM . A double‐blind comparison of quinine sulphate and placebo in muscle cramps. Age and Ageing1983;12(2):155‐8. [PUBMED: 6346830] ">Jones 1983</a>; <a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>; <a href="./references#CD005044-bbs2-0020" title="SidorovJ . Quinine sulfate for leg cramps: does it work?. Journal of the American Geriatrics Society1993;41(5):498‐500. [PUBMED: 8486881] ">Sidorov 1993</a>), but data from six trials (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>; <a href="./references#CD005044-bbs2-0010" title="JansenPH , VeenhuizenKC , VerbeekAL , StraatmanH . Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. Journal of the Neurological Sciences1994;122(2):157‐61. [PUBMED: 8021700] ">Jansen 1994</a>; <a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a>; <a href="./references#CD005044-bbs2-0012" title="JonesK , CastledenCM . A double‐blind comparison of quinine sulphate and placebo in muscle cramps. Age and Ageing1983;12(2):155‐8. [PUBMED: 6346830] ">Jones 1983</a>; <a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>) could not be entered into the meta‐analysis because the data could not be ascertained or converted into a suitable form or were unavailable from the trial authors. All except one (<a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>) of these excluded trials individually showed that there was no significant difference between quinine and placebo with regards to cramp duration. A further trial (<a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a>) combined cramp duration with mean severity to give a 'cramp index'; no significant difference in this index was found between quinine and placebo. </p> <p>There remained two trials (n = 28; <a href="./references#CD005044-bbs2-0007" title="FungMC , HolbrookJH . Placebo‐controlled trial of quinine therapy for nocturnal leg cramps. Western Journal of Medicine1989;151(1):42‐4. [PUBMED: 2669346] ">Fung 1989</a>; <a href="./references#CD005044-bbs2-0020" title="SidorovJ . Quinine sulfate for leg cramps: does it work?. Journal of the American Geriatrics Society1993;41(5):498‐500. [PUBMED: 8486881] ">Sidorov 1993</a>) which could be combined into the meta‐analysis. Cramp durations were calculated from individual patient data provided in the <a href="./references#CD005044-bbs2-0007" title="FungMC , HolbrookJH . Placebo‐controlled trial of quinine therapy for nocturnal leg cramps. Western Journal of Medicine1989;151(1):42‐4. [PUBMED: 2669346] ">Fung 1989</a> trial. We used a random‐effects model because of unexplained significant heterogeneity (I² = 31%), and there was no significant difference between quinine and placebo (‐1.35 minutes, 95% CI ‐4.00 to 1.30) (see <a href="./references#CD005044-fig-0013" title="">Analysis 1.5</a>). </p> </section> <section id="CD005044-sec-0054"> <h5 class="title">Change in number of cramp days</h5> <p>Ten trials measured this outcome and seven reported statistically significant reductions in the number of cramp days with quinine compared with placebo. However, one of these trials (<a href="./references#CD005044-bbs2-0006" title="DunnNR . Effectiveness of quinine for night cramps. British Journal of General Practice1993;43(368):127‐8. [PUBMED: 8323792] ">Dunn 1993</a>) could not be entered into the meta‐analysis as it was a cross‐over trial that was declared invalid by its authors because of a significant carry‐over effect. <a href="./references#CD005044-bbs2-0016" title="LimSH . Randomised double‐blind trial of quinine sulphate for nocturnal leg cramp. British Journal of Clinical Practice1986;40(11):462. [PUBMED: 3307858] ">Lim 1986</a> could not be entered into the meta‐analysis as it failed to indicate the number of participants in each group. </p> <p>Eight trials were combined (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>; <a href="./references#CD005044-bbs2-0005" title="DienerHC , DethlefsenU , Dethlefsen‐GruberS , VerbeekP . Effectiveness of quinine in treating muscle cramps: a double‐blind, placebo‐controlled, parallel‐group, multicentre trial. International Journal of Clinical Practice2002;56(4):243‐6. [PUBMED: 12074203] ">Diener 2002</a>; <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>; <a href="./references#CD005044-bbs2-0009" title="HaysRM , Goodman JJ (for SchollInc.) . Clinical trial of the efficacy of quinine sulfate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Hays 1986</a>; <a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>; <a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a>). Results were standardised to two weeks. The three unpublished trials (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0009" title="HaysRM , Goodman JJ (for SchollInc.) . Clinical trial of the efficacy of quinine sulfate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Hays 1986</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>) reported differences in the number of cramp days without details of standard deviation or confidence limits. These were approximately derived from the P values given. The trial of <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> was excluded after sensitivity analysis because of the demonstrable heterogeneity that it contributed. The remaining seven trials (n = 842) showed that quinine significantly reduced cramp days compared to placebo (‐1.15 days, 95% CI ‐1.93 to ‐0.38, random‐effects) (see <a href="./references#CD005044-fig-0014" title="">Analysis 1.6</a>). This represents a 20% (95% CI 6% to 33%) reduction in cramp days when compared to the average number of affected days on placebo. It is worth noting that despite the exclusion of <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>, there remained significant heterogeneity between the trials (I² = 86%). </p> </section> <section id="CD005044-sec-0055"> <h5 class="title">Participants with one or more adverse events</h5> <p>All but one of the included trials provided results for adverse events, investigated by participant diary or clinical assessment, or both. The trial that did not mention adverse events set out with the intention to do so but no mention of this was later given in the paper (<a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a>). The data on adverse events in the <a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a> trial were unclear and could not be entered into the meta‐analysis. Only data for major adverse events from the <a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a> trial could be entered into the meta‐analysis. </p> <section id="CD005044-sec-0056"> <h6 class="title">Minor adverse events</h6> <p>Sixteen of the 20 placebo‐controlled trials provided accurate data on minor adverse events. Quinine was free of all adverse events in six trials with a total of 106 participants (<a href="./references#CD005044-bbs2-0006" title="DunnNR . Effectiveness of quinine for night cramps. British Journal of General Practice1993;43(368):127‐8. [PUBMED: 8323792] ">Dunn 1993</a>; <a href="./references#CD005044-bbs2-0012" title="JonesK , CastledenCM . A double‐blind comparison of quinine sulphate and placebo in muscle cramps. Age and Ageing1983;12(2):155‐8. [PUBMED: 6346830] ">Jones 1983</a>; <a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>; <a href="./references#CD005044-bbs2-0016" title="LimSH . Randomised double‐blind trial of quinine sulphate for nocturnal leg cramp. British Journal of Clinical Practice1986;40(11):462. [PUBMED: 3307858] ">Lim 1986</a>; <a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a>; <a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a>). </p> <p>When the 16 trials were combined, 93 out of 725 participants on quinine suffered minor adverse events (12.8%), compared to 68 out of 722 on placebo (9.4%). The risk difference (RD) was small but significant at 3% (95% CI 0% to 6%) (<a href="./references#CD005044-fig-0015" title="">Analysis 1.7</a>, <a href="#CD005044-fig-0003">Figure 3</a>). There was no heterogeneity in the results (I² = 0%). </p> <div class="figure" id="CD005044-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.7 Participants suffering minor adverse events ‐ fixed‐effect." data-id="CD005044-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.7 Participants suffering minor adverse events ‐ fixed‐effect. </p> </div> </div> </div> <p>In a separate analysis of specific minor adverse events, the <a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a> and <a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a> trials could also be taken into account, giving a total of 790 participants in the quinine group and 791 in the placebo group. Comparing quinine with placebo, the following numbers of participants suffered the respective minor adverse events: gastrointestinal (39 quinine versus 16 placebo), headache (36 versus 33), tinnitus (10 versus 1), pruritis/scaly rash (9 versus 3), dizziness/drowsiness (8 versus 8), myalgia/paraesthesia (7 versus 10), visual disturbance (4 versus 2), and fever (3 versus 1). The only significant risk difference was found to be gastrointestinal‐related adverse events (RD 3%, 95% CI 1% to 5%) (<a href="./references#CD005044-fig-0016" title="">Analysis 1.8</a>, <a href="#CD005044-fig-0004">Figure 4</a>). The apparent increase in incidence of tinnitus did not reach statistical significance. </p> <div class="figure" id="CD005044-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.8 Participants suffering specific minor adverse events." data-id="CD005044-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.8 Participants suffering specific minor adverse events. </p> </div> </div> </div> </section> <section id="CD005044-sec-0057"> <h6 class="title">Major adverse events</h6> <p>Quinine was stopped in a total of 12 participants in eight separate trials because of adverse events. Twelve participants (1.5%) withdrew from a total of 806 participants treated with quinine compared to 11 out of 807 on placebo (1.4%). There was no significant risk difference between the two groups (RD 0.0%; 95% CI ‐1% to 2%) (<a href="./references#CD005044-fig-0017" title="">Analysis 1.9</a>, <a href="#CD005044-fig-0005">Figure 5</a>). There was no heterogeneity in the results (I² = 0%). </p> <div class="figure" id="CD005044-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.9 Participants suffering major adverse events." data-id="CD005044-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.9 Participants suffering major adverse events. </p> </div> </div> </div> <p>The only truly serious adverse event occurred in the <a href="./references#CD005044-bbs2-0020" title="SidorovJ . Quinine sulfate for leg cramps: does it work?. Journal of the American Geriatrics Society1993;41(5):498‐500. [PUBMED: 8486881] ">Sidorov 1993</a> cross‐over trial (n = 19), where a participant suffered leukopenia and thrombocytopenia with a severe rash, myalgia, and nausea, all of which resolved three days after stopping quinine. No further details are available regarding this participant. </p> <p>The other adverse events encountered were mild or short‐lived, with authors usually reporting their resolution on cessation of treatment. Several participants suffered more than one major adverse event and by symptomatology these were: gastrointestinal (7 in quinine group versus 1 in placebo group), dizziness/drowsiness (3 versus 2), headache (2 versus 2), pruritis/scaly rash (2 versus 0), tinnitus (1 versus 0), myalgia/paraesthesia (1 versus 0), visual disturbance (0 versus 1), and fever (1 versus 0). Gastrointestinal symptoms were the commonest reason for participant withdrawal but this was not significantly different to placebo (<a href="./references#CD005044-fig-0018" title="">Analysis 1.10</a>, <a href="#CD005044-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD005044-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.10 Participants suffering specific major adverse events (gastrointestinal)." data-id="CD005044-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.10 Participants suffering specific major adverse events (gastrointestinal). </p> </div> </div> </div> </section> </section> </section> <section id="CD005044-sec-0058"> <h4 class="title">Quinine versus vitamin E</h4> <p>Four trials (n = 543) compared quinine against vitamin E at doses of 1600 units (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>) and 800 units (<a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>; <a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>). </p> <section id="CD005044-sec-0059"> <h5 class="title">Primary outcome measure: difference in number of cramps (occurring day or night) during a two‐week treatment period </h5> <p>The inclusion of <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> resulted in significant heterogeneity (I² = 94%, reduced to 29% on exclusion), so it was removed on the basis of its unique selection of participants and dose. With this persisting heterogeneity (I² = 29%), we used the random‐effects model and there was no significant difference between quinine and vitamin E in reducing cramps; ‐0.24 cramps (95% CI ‐1.29 to 0.81) (see <a href="./references#CD005044-fig-0019" title="">Analysis 2.1</a>, <a href="#CD005044-fig-0007">Figure 7</a>). </p> <div class="figure" id="CD005044-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Quinine versus vitamin E, outcome: 2.1 Difference in number of cramps in 2 weeks ‐ random‐effects (minus Connolly 1992)." data-id="CD005044-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Quinine versus vitamin E, outcome: 2.1 Difference in number of cramps in 2 weeks ‐ random‐effects (minus Connolly 1992). </p> </div> </div> </div> </section> <section id="CD005044-sec-0060"> <h5 class="title">Change in cramp intensity during treatment period</h5> <p>Four trials (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>; <a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>) compared quinine to vitamin E, and in none was there a significant difference between the two treatments in reducing cramp intensity. </p> <p>Following sensitivity analysis, <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> was again removed, reducing I² to 0. The combined result from the remaining three trials (n = 513) showed that quinine was not significantly better than vitamin E in reducing cramp intensity (‐0.06 units, 95% CI ‐0.17 to 0.04, see <a href="./references#CD005044-fig-0020" title="">Analysis 2.2</a>). </p> </section> <section id="CD005044-sec-0061"> <h5 class="title">Change in cramp duration (in minutes)</h5> <p>Only one trial (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>, n = 256) measured cramp duration for this comparison. A descriptive scale was used (0 'none', 1 'short', 2 'moderate' and 3 'long') and the difference between quinine and vitamin E on this scale was nonsignificant at two weeks (‐0.06 units, 95% CI ‐0.13 to 0.01). </p> </section> <section id="CD005044-sec-0062"> <h5 class="title">Change in number of cramp days</h5> <p>From the four trials comparing quinine with vitamin E, the number of cramp days was an outcome in three (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>). The smaller study of <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> did not provide statistical comparison of quinine with vitamin E, but did provide sufficient data for this analysis to be made without any statistical assumption; at two weeks, quinine was significantly better than vitamin E in reducing cramp days (‐2.85, 95% CI ‐3.32 to ‐2.38). However, the trial of <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> was excluded from the final meta‐analysis (n = 483) due to high heterogeneity (I² dropping from 98% to 48% on exclusion). Accepting the persisting significant heterogeneity, there was no significant difference when quinine was compared to vitamin E (‐0.28 cramp days, 95% CI ‐0.98 to 0.43, random‐effects) (see <a href="./references#CD005044-fig-0021" title="">Analysis 2.3</a>). </p> </section> <section id="CD005044-sec-0063"> <h5 class="title">Participants with one or more adverse events</h5> <p>Three of the four vitamin E trials provided results for adverse events. The trial that did not mention adverse events set out with the intention to do so but no mention of this was later given in the paper (<a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>). </p> <section id="CD005044-sec-0064"> <h6 class="title">Minor adverse events</h6> <p>Two studies (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>) were entered into the meta‐analysis as <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> failed to give any detail on minor adverse events. Sixty‐nine participants (19.9%) from a total of 346 participants treated with quinine experienced minor adverse events compared to 57 out of 342 on vitamin E (16.7%). There was no significant risk difference between the two groups (RD 2%, 95% CI ‐4% to 9%, random‐effects) (<a href="./references#CD005044-fig-0022" title="">Analysis 2.4</a>). There was unexplained heterogeneity (I² = 36%). </p> <p>Several participants suffered more than one minor adverse event and by symptomatology these were mainly: headache (29 in quinine group versus 24 in vitamin E group), gastrointestinal (17 versus 14), tinnitus (4 versus 0), and visual disturbance (1 versus 3). </p> </section> <section id="CD005044-sec-0065"> <h6 class="title">Major adverse events</h6> <p>Three studies (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>) could be entered into the meta‐analysis. Four participants (1.06%) withdrew from a total of 376 participants treated with quinine compared to one of 372 participants on vitamin E (0.27%). There was no significant risk difference between the two groups (RD 1%, 95% CI ‐1% to 2%) (<a href="./references#CD005044-fig-0023" title="">Analysis 2.5</a>). We used a random‐effects model, as the exclusion of <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> did not reduce the significant heterogeneity found with the fixed‐effect model. </p> <p>The four withdrawals from the quinine groups all complained of gastrointestinal symptoms, but also rash and paraesthesia (one participant), headache (two participants), and pruritus with bruising (one participant). This last participant would not permit follow‐up (<a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>), whilst all symptoms resolved soon after cessation of quinine in the other three (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>). The only participant to withdraw from the vitamin E group suffered from severe headache with nausea and vomiting, but was found to have a history of migraine. </p> </section> </section> </section> <section id="CD005044-sec-0066"> <h4 class="title">Quinine versus a quinine‐vitamin E combination</h4> <section id="CD005044-sec-0067"> <h5 class="title">Primary outcome measure: difference in number of cramps (occurring day or night) during a two‐week treatment period </h5> <p>Three unpublished studies (n = 510) compared quinine with a combination of quinine and vitamin E (Q‐Vel); two of these trials claimed superiority of the quinine‐vitamin E combination over quinine alone (<a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>), whilst one reported no significant difference (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>). The <a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a> study did not report data that could be included in the meta‐analysis. We identified significant heterogeneity in the meta‐analysis of the remaining two studies (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>). This could not be explained, so we used a random‐effects model (I² = 49%); there was a nonsignificant difference in cramp number when quinine alone was compared to the quinine‐vitamin E combination (1.07 cramps, 95% CI ‐1.08 to 3.23) (see <a href="./references#CD005044-fig-0024" title="">Analysis 3.1</a>, <a href="#CD005044-fig-0008">Figure 8</a>). </p> <div class="figure" id="CD005044-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), outcome: 3.1 Difference in number of cramps in 2 weeks ‐ random‐effects." data-id="CD005044-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), outcome: 3.1 Difference in number of cramps in 2 weeks ‐ random‐effects. </p> </div> </div> </div> </section> <section id="CD005044-sec-0068"> <h5 class="title">Change in cramp intensity during treatment period</h5> <p>Three trials (n = 510), all unpublished, compared quinine to a quinine‐vitamin E combination (<a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a>; <a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>) and reported the change in cramp intensity. </p> <p>We used a random‐effects model for the meta‐analysis because of unexplained heterogeneity. Accepting significant heterogeneity (I² = 74%) in the results, there was no significant difference between quinine and the quinine‐vitamin E combination with regards to cramp intensity (0.10, 95% CI ‐0.06 to 0.26) (see <a href="./references#CD005044-fig-0025" title="">Analysis 3.2</a>). </p> </section> <section id="CD005044-sec-0069"> <h5 class="title">Change in cramp duration (in minutes)</h5> <p>Two trials (n = 299) measured cramp duration for this comparison, but could not be included in a meta‐analysis as grouped (<a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a>) or descriptive (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>) data only were available. There was no significant difference between quinine and quinine‐vitamin E combination in either study. </p> </section> <section id="CD005044-sec-0070"> <h5 class="title">Change in number of cramp days</h5> <p>Two of the three trials involving a quinine‐vitamin E combination measured the number of cramp days as an outcome (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>). The combined result of these two trials (n = 486) showed no significant difference between quinine and the quinine‐vitamin E combination (0.18 cramp days, 95% CI ‐1.13 to 1.49, random‐effects) (see <a href="./references#CD005044-fig-0026" title="">Analysis 3.3</a>). There was however significant unexplained heterogeneity (81%) in the results. </p> </section> <section id="CD005044-sec-0071"> <h5 class="title">Participants with one or more adverse events</h5> <section id="CD005044-sec-0072"> <h6 class="title">Minor adverse events</h6> <p>Three trials (<a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a>; <a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>) were entered in the meta‐analysis. Seventy‐two participants out of the 370 (19.5%) taking quinine suffered from minor adverse events compared to 64 from 369 (17.3%) taking the quinine‐vitamin E combination. We used a random‐effects model as there was significant heterogeneity that could not be explained. The weighted RD was not significant at 3% (95% CI ‐4% to 10%) (<a href="./references#CD005044-fig-0027" title="">Analysis 3.4</a>). The adverse events mainly included: headache (29 participants on quinine versus 29 on quinine‐vitamin E), gastrointestinal (20 versus 17), tinnitus (4 versus 4), rashes (2 versus 0), pruritis (3 versus 1), visual disturbance (1 versus 1). </p> </section> <section id="CD005044-sec-0073"> <h6 class="title">Major adverse events</h6> <p>Three trials (<a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a>; <a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>) were entered in the meta‐analysis. There were no major adverse events in the <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a> (n = 205) or <a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a> (n = 24) cross‐over trials. There were three participant withdrawals from each group in the <a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a> trial. Thus, three participants (0.81%) withdrew from a total of 370 participants treated with quinine compared to three out of 369 on the quinine‐vitamin E combination (0.81%). The combined meta‐analysis thus showed no risk difference (RD 0%, 95% CI ‐1% to 1%) (<a href="./references#CD005044-fig-0028" title="">Analysis 3.5</a>). </p> <p>The adverse events suffered by those participants withdrawing from the quinine‐vitamin E group included: flu‐like symptoms, mild tinnitus, nausea, vomiting and diarrhoea, all of which resolved on cessation of medication. One participant was hospitalised with abdominal pain, headache, diffuse myalgias and fever, but their condition was never judged to be serious and improved with cessation of treatment (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>). The three withdrawals from the quinine group all complained of gastrointestinal symptoms but also headache in one, and rash and paraesthesia in another (<a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>). Again all resolved on cessation of treatment. </p> </section> </section> </section> <section id="CD005044-sec-0074"> <h4 class="title">Quinine versus a quinine‐theophylline combination</h4> <section id="CD005044-sec-0075"> <h5 class="title">Primary outcome measure: difference in number of cramps (occurring day or night) during a two‐week treatment period </h5> <p>A single parallel‐group study conducted by a pharmaceutical company (<a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>, n = 77 excluding placebo group) compared quinine to a quinine‐theophylline combination known as Limptar<sup>®</sup>. Standardised results from the second treatment week showed quinine was at a significant disadvantage compared to the quinine‐theophylline combination, giving 3.8 more cramps (95% CI 1.08 to 6.52) over two weeks, representing a 136% (95% CI 39% to 233%) difference. </p> </section> <section id="CD005044-sec-0076"> <h5 class="title">Change in cramp intensity during treatment period</h5> <p>The <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a> trial (n = 77 excluding placebo group) found that quinine alone was significantly less effective than the quinine‐theophylline combination in reducing cramp intensity (0.32 units, 95% CI 0.11 to 0.53) on a three‐point scale, representing a 168% (95% CI 58% to 279%) higher intensity. </p> </section> <section id="CD005044-sec-0077"> <h5 class="title">Change in cramp duration (in minutes)</h5> <p>The <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a> trial (n = 77) grouped cramp duration into three time intervals, meaning that individual cramp durations could not be ascertained. However, on their three‐point scale, quinine alone was significantly less effective than the quinine‐theophylline combination in reducing cramp duration (0.17 units, 95% CI 0.06 to 0.28), representing a 106% (95% CI 38% to 175%) longer cramp duration with quinine. </p> </section> <section id="CD005044-sec-0078"> <h5 class="title">Change in number of cramp days</h5> <p>The <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a> study (n = 77) reported a significantly higher incidence of cramp days over two weeks (2.2 cramp days, 95% CI 0.58 to 3.82) with the quinine group compared to the quinine‐theophylline combination, representing a 101% increase (95% CI 27% to 175%). </p> </section> <section id="CD005044-sec-0079"> <h5 class="title">Participants with one or more adverse events</h5> <section id="CD005044-sec-0080"> <h6 class="title">Minor adverse events</h6> <p>In the <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a> trial, four participants suffered adverse events in the quinine‐theophylline combination group (n = 34). These included low blood pressure with dizziness (one participant), nausea and palpitations (two participants) and tinnitus (one participant). Three of these participants withdrew from the study but it is not clear from the study which participants these were. There was thus one minor adverse event in the quinine‐theophylline group (n = 34), which compares with one minor adverse event (nausea and vomiting) in the quinine group (n = 43) (<a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>). </p> </section> <section id="CD005044-sec-0081"> <h6 class="title">Major adverse events</h6> <p>There were three withdrawals from the quinine‐theophylline group (n = 34), and this compares with two drop‐outs from the quinine group (n = 43), with nausea and vomiting. </p> </section> </section> </section> <section id="CD005044-sec-0082"> <h4 class="title">Quinine versus xylocaine injection</h4> <p><a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a> (n = 24) was the only trial to compare quinine with 1% xylocaine injections into the medial head of the gastrocnemius muscle. Both treatments reduced cramp number significantly from baseline but there was no significant difference between the groups after four weeks treatment. However, xylocaine's beneficial effect lasted longer; four weeks after treatment cessation, quinine had a significant disadvantage compared to xylocaine (1.35 cramps, 95% CI 0.52 to 2.18). </p> <section id="CD005044-sec-0083"> <h5 class="title">Change in cramp intensity during treatment period</h5> <p>In the <a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a> trial (n = 24) both treatments reduced cramp intensity significantly from baseline, but there was no significant difference between the groups at four weeks. However, at the follow‐up appointment four weeks after treatment cessation, the quinine group was at a significant disadvantage compared to xylocaine (0.72 units on a three‐point scale, 95% CI 0.24 to 1.20). </p> </section> <section id="CD005044-sec-0084"> <h5 class="title">Change in cramp duration (in minutes)</h5> <p>In the <a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a> trial (n = 24) both treatments reduced cramp duration significantly from baseline, but there was no significant difference between the groups at four weeks. However, at the follow‐up appointment four weeks after treatment cessation, quinine was at a significant disadvantage compared to xylocaine (0.5 minutes, 95% CI 0.09 to 0.91). </p> </section> <section id="CD005044-sec-0085"> <h5 class="title">Change in number of cramp days</h5> <p>The number of cramp days was not an outcome in the <a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a> trial. </p> </section> <section id="CD005044-sec-0086"> <h5 class="title">Participants with one or more adverse events</h5> <section id="CD005044-sec-0087"> <h6 class="title">Minor adverse events</h6> <p>There were no minor adverse events in the <a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a> study. </p> </section> <section id="CD005044-sec-0088"> <h6 class="title">Major adverse events</h6> <p>The <a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a> study reported the withdrawal of two participants from the quinine treatment group (n = 10) due to 'cinchonism'. Details of the specific adverse events experienced by each participant were not provided, and no follow‐up is given. No adverse events occurred in the xylocaine injection group (n = 12). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005044-sec-0089" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005044-sec-0089"></div> <section id="CD005044-sec-0090"> <h3 class="title" id="CD005044-sec-0090">Quinine versus placebo</h3> <p>There is low quality evidence of a statistically significant benefit of quinine in reducing cramp number over two weeks (the primary outcome) and moderate quality evidence for a reduction in cramp intensity (<a href="./full#CD005044-tbl-0001">summary of findings Table for the main comparison</a>). Quinine also reduced the number of cramp days over two weeks. The only outcome which was not significantly different from placebo was that of cramp duration. The Summary of findings table does not present data for cramp duration and cramp days, but using GRADE criteria, we consider the quality of the evidence for these outcomes as moderate and low, respectively, owing to study design limitations and additionally for cramp days, heterogeneity. </p> <p>Significant unexplained heterogeneity was notable in many of the meta‐analyses, reflecting the variable results between the included studies, and this may reduce the confidence in the conclusions. It is this heterogeneity which has led to the lack of a clear consensus on this subject. As little is known about the pathophysiology of cramps or the mechanism of action of quinine, it is difficult to explain why quinine should have no significant effect on cramp duration, yet seems to reduce cramp number and intensity. However, cramp duration is probably the most difficult to judge. </p> <p>The first meta‐analysis by Man‐Son‐Hing included six small cross‐over trials (n = 107) (<a href="./references#CD005044-bbs2-0070" title="Man‐Son‐HingM , WellsG . Meta‐analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people. BMJ1995;310(6971):13‐17. ">Man‐Son‐Hing 1995</a>). Later, the same group performed a second meta‐analysis that included four published and three unpublished trials (n = 659) (<a href="./references#CD005044-bbs2-0071" title="Man‐Son‐HingM , WellsG , LauA . Quinine for nocturnal leg cramps: a meta‐analysis including unpublished data. Journal of General Internal Medicine1998;13(9):600‐6. ">Man‐Son‐Hing 1998</a>); this demonstrated that quinine was effective in reducing cramp number (21% reduction; 95% CI 12% to 30%), and intensity (‐0.13 unit on a three‐point scale, P = 0.002). This is broadly in line with the results of our meta‐analysis. </p> <p>The American Academy of Neurology reviewed a variety of treatments for muscle cramp and found that there was Level A evidence that quinine was effective (<a href="./references#CD005044-bbs2-0060" title="KatzbergHD , KhanAH , SoYT . Assessment: symptomatic treatment for muscle cramps (an evidence‐based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology2010;74(8):691–6. ">Katzberg 2010</a>). As this was not a meta‐analysis, there are no figures for comparison. Only 12 studies containing quinine were included in the review, and none of these were unpublished trials. The report recommends the avoidance of quinine for leg cramps unless absolutely necessary, because of its potentially serious side‐effect profile. The review of adverse events also consisted of case reports and case series where high doses of quinine were being used for the treatment of malaria. </p> </section> <section id="CD005044-sec-0091"> <h3 class="title" id="CD005044-sec-0091">Quinine versus other treatments</h3> <p>This meta‐analysis showed there was no significant difference between quinine and vitamin E, or between quinine and a quinine‐vitamin E combination (<a href="./full#CD005044-tbl-0002">summary of findings Table 2</a> and <a href="./full#CD005044-tbl-0003">summary of findings Table 3</a>). This would suggest that vitamin E alone may be as effective as quinine in reducing cramp number, intensity, and days, but that its effect when combined with quinine is not significantly additive. </p> <p>We removed <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> after sensitivity analyses for methodological reasons. However, inclusion of this study would make quinine seem significantly more effective than vitamin E at reducing cramp number and days. Vitamin E is generally regarded as safe, but a meta‐analysis (<a href="./references#CD005044-bbs2-0079" title="MillerER3rd , Pastor‐BarriusoR , DalalD , RiemersmaRA , AppelLJ , GuallarE . Meta‐analysis: high‐dosage vitamin E supplementation may increase all‐cause mortality. Annals of Internal Medicine2005;142(1):37‐46. ">Miller 2005</a>) suggested that high‐dose vitamin E (400 IU/d or more) may increase all‐cause mortality and should be avoided. </p> <p>A single study (n = 77) performed by a pharmaceutical company suggested that a quinine‐theophylline combination was significantly more effective than quinine alone across all outcomes (<a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a>). There were no additional adverse events. More trials are needed containing quinine‐theophylline to support or refute these findings. </p> <p>Cramps with an identified myofascial trigger point may be more unusual. One trial (<a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a>, n = 24) showed that quinine did not differ significantly from xylocaine injections into these trigger points after four weeks treatment, but that the xylocaine injections were significantly more effective at the eight‐week follow‐up (four weeks after treatment cessation). Further long‐term studies are required to replicate this finding and assess the feasibility of its application. </p> </section> <section id="CD005044-sec-0092"> <h3 class="title" id="CD005044-sec-0092">Effect of quinine dose and duration</h3> <section id="CD005044-sec-0093"> <h4 class="title">Dose</h4> <p>Accumulation of quinine with daily dosing can be expected because its half‐life is between 9 and 11 hours in young people (<a href="./references#CD005044-bbs2-0038" title="BerlinCM , StackmanJM , VesellES . Quinine‐induced alterations in drug disposition. Clinical Pharmacology and Therapeutics1975;18(6):670‐9. ">Berlin 1975</a>; <a href="./references#CD005044-bbs2-0084" title="Mutual PharmaceuticalCompany . Quinine sulfate [package insert]. Philadelphia, PA: 2006. thomsonweb.esourcegroup.com/files/PI_0.pdf (accessed 2 February 2009). ">Mutual 2006</a>) and up to 19 hours in the elderly (<a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a>; <a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a>). Despite these pharmacokinetic changes in the elderly, an alteration in the quinine dosage regimen in elderly people is not recommended by the manufacturers of one quinine product (Qualaquin) (<a href="./references#CD005044-bbs2-0084" title="Mutual PharmaceuticalCompany . Quinine sulfate [package insert]. Philadelphia, PA: 2006. thomsonweb.esourcegroup.com/files/PI_0.pdf (accessed 2 February 2009). ">Mutual 2006</a>). </p> <p>Two trials showed a significant positive correlation between serum quinine levels and reductions in cramp number (<a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>; <a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a>), whilst one trial showed no correlation (<a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a>). In the <a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a> trial where 200 mg quinidine was given twice daily, the mean (SD) peak and trough serum levels at two weeks were 1.3 (0.1) mg/L and 0.7 (0.1) mg/L respectively. Two participants who did not show a significant response to quinidine were found to have low trough serum levels (0.2 mg/L and 0.3 mg/L); upon increasing the dose to 600 mg daily, trough levels improved to 0.6 and 0.7 mg/L and significant reductions in cramp number were then achieved. This indicates that quinine therapy may benefit from monitoring serum drug levels and adjusting dosage accordingly. Further trials are needed to elucidate the optimum therapeutic range for quinine in muscle cramps. </p> <p>In the trials identified for this meta‐analysis, there was a trend of increasing effect with quinine doses of 300 mg to 500 mg. However, the results with lower doses (200 mg to 260 mg) go against this trend. This, however, is a very limited analysis as there was a shortage of studies in each dosage group and also several confounding variables. The <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> trial was the only one to use a dose of 500 mg quinine; the adverse events experienced were comparable to those in the other trials. </p> </section> <section id="CD005044-sec-0094"> <h4 class="title">Duration</h4> <p>The optimum treatment duration with quinine has equally not been investigated. The <a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> study suggested that quinine was rapidly effective, achieving a 50% reduction in cramp number in almost half the participants by three days. One trial (<a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>) showed that a short five‐day course was sufficient to bring about significant change, whilst two trials recommended seven days (<a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a>; <a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a>). </p> <p>Most studies showed greater effect the longer quinine was continued; for example, cramp reductions were more significant in the second treatment week than the first in the <a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a> trial. However, the opposite was found in the <a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a> trial where significant reductions after week one became nonsignificant in week two. The duration of treatment varied from 5 to 60 days in the included trials. Of the five trials with the greatest reductions in cramp number by quinine, four were achieved by the longest trials, with treatment durations of 42 days (<a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a>) and 28 days (<a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>; <a href="./references#CD005044-bbs2-0007" title="FungMC , HolbrookJH . Placebo‐controlled trial of quinine therapy for nocturnal leg cramps. Western Journal of Medicine1989;151(1):42‐4. [PUBMED: 2669346] ">Fung 1989</a>; <a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>). </p> <p>Quinine was found to have significant lasting effects at two weeks after treatment cessation in three trials (<a href="./references#CD005044-bbs2-0005" title="DienerHC , DethlefsenU , Dethlefsen‐GruberS , VerbeekP . Effectiveness of quinine in treating muscle cramps: a double‐blind, placebo‐controlled, parallel‐group, multicentre trial. International Journal of Clinical Practice2002;56(4):243‐6. [PUBMED: 12074203] ">Diener 2002</a>; <a href="./references#CD005044-bbs2-0010" title="JansenPH , VeenhuizenKC , VerbeekAL , StraatmanH . Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. Journal of the Neurological Sciences1994;122(2):157‐61. [PUBMED: 8021700] ">Jansen 1994</a>; <a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a>), and at four weeks in another (<a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a>). If continuous therapy is not needed, then knowing the duration of quinine's effect after cessation will allow the determination of suitable periods for 'drug holidays' and also for the required washout periods in new trials. </p> </section> </section> <section id="CD005044-sec-0095"> <h3 class="title" id="CD005044-sec-0095">Adverse events due to quinine</h3> <p>The adverse events attributed to quinine can be divided into three types: those arising from hypersensitivity reactions which may occur immediately or after years of treatment (thrombocytopenia, disseminated intravascular coagulation, acute renal failure, haemolytic uraemic syndrome), those reversible adverse events that are dose‐dependent and can occur with normal use (gastrointestinal upset, tinnitus, vertigo, visual disturbance), and those that arise from toxic overdose (cardiac arrhythmias, blindness, seizures) (<a href="./references#CD005044-bbs2-0037" title="BatemanDN , BlainPG , WoodhouseKW , RawlinsMD , DysonH , HeyworthR , et al. Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. Quarterly Journal of Medicine1985;54(214):125‐31. ">Bateman 1985</a>; <a href="./references#CD005044-bbs2-0063" title="KnowerMT , BowtonDL , OwenJ , DunaganDP . Quinine‐induced disseminated intravascular coagulation: case report and review of the literature. Intensive Care Medicine2003;29(6):1007‐11. ">Knower 2003</a>; <a href="./references#CD005044-bbs2-0082" title="MortonAP . Quinine‐induced disseminated intravascular coagulation and haemolytic‐uraemic syndrome. Medical Journal of Australia2002;176(7):351. ">Morton 2002</a>; <a href="./references#CD005044-bbs2-0095" title="PrasadRS , KodaliVR , KhuraijamGS , ChoM , TraversJP . Acute confusion and blindness from quinine toxicity. European Journal of Emergency Medicine2003;10(4):353‐6. ">Prasad 2003</a>; <a href="./references#CD005044-bbs2-0098" title="SchneemannM . Quinine. In: AronsonJK editor(s). Meyler's Side Effects of Drugs. 15th Edition. New York: Elsevier Science, 2006:3002‐7. ">Schneemann 2006</a>). All but one of the adverse events occurring from the trials included in this meta‐analysis fall into the second group; these dose‐related adverse events can occur with normal therapeutic use of quinine, but are more common when plasma quinine levels rise above 5 mg/L (<a href="./references#CD005044-bbs2-0072" title="MandalAK , AbernathyT , NelluriSN , StitzelV . Is quinine effective and safe in leg cramps?. Journal of Clinical Pharmacology1995;35(6):588‐93. ">Mandal 1995</a>; <a href="./references#CD005044-bbs2-0098" title="SchneemannM . Quinine. In: AronsonJK editor(s). Meyler's Side Effects of Drugs. 15th Edition. New York: Elsevier Science, 2006:3002‐7. ">Schneemann 2006</a>). </p> <p>Quinine has been implicated in accidental and intentional poisoning. The Scottish Poisons Information Bureau reported 96 such cases (out of a population of 5.2 million) over five years across a wide range of ages and overdosage; 38% of these patients were asymptomatic, 23% suffered visual toxicity, 19% auditory toxicity, 15% cardiotoxicity, 14% gastrointestinal symptoms, and 11% reduced Glasgow Coma Scale (<a href="./references#CD005044-bbs2-0065" title="LangfordNJ , GoodAM , LaingWJ , BatemanDN . Quinine intoxications reported to the Scottish Poisons Information Bureau 1997‐2002: a continuing problem. British Journal of Clinical Pharmacology2003;56(5):576‐8. ">Langford 2003</a>). </p> <p>Renal impairment and interactions with other medication (such as digoxin, anticoagulants and phenothiazines) must also be borne in mind (<a href="./references#CD005044-bbs2-0091" title="PedersenKE , Lysgaard MadsenJ , KlitgaardNA , KjaerK , HvidtS . Effect of quinine on plasma digoxin concentration and renal digoxin clearance. Acta Medica Scandinavica1985;218(2):229‐32. ">Pederson 1985</a>), as well as the fact that memory loss in the elderly may make people vulnerable to overdosage of quinine. </p> <p>This meta‐analysis showed that significantly more people suffered minor adverse events on quinine than placebo but no difference in major adverse events. Gastrointestinal upset in the form of nausea, vomiting and abdominal pain was the most common adverse event (5.7%, n = 806), followed by headache (4.7%), and tinnitus (1.4%). Pruritus, scaly rashes, dizziness, visual disturbances, and fever were rare. The only minor adverse events that were significantly higher with quinine were gastrointestinal events. This compares with <a href="./references#CD005044-bbs2-0071" title="Man‐Son‐HingM , WellsG , LauA . Quinine for nocturnal leg cramps: a meta‐analysis including unpublished data. Journal of General Internal Medicine1998;13(9):600‐6. ">Man‐Son‐Hing 1998</a> which showed that tinnitus was the only minor adverse event that was significantly more common with quinine. </p> <p>Though 12 participants withdrew from quinine treatment due to side effects, these tended to be benign adverse events, and may or may not have been related to quinine; indeed, a total of 11 participants withdrew from placebo treatment, some with similar adverse events. There was however one serious adverse event which was likely to be attributed to quinine: one participant in the <a href="./references#CD005044-bbs2-0020" title="SidorovJ . Quinine sulfate for leg cramps: does it work?. Journal of the American Geriatrics Society1993;41(5):498‐500. [PUBMED: 8486881] ">Sidorov 1993</a> trial suffered leukopenia and thrombocytopenia, with a severe rash, myalgia, and nausea. His symptoms resolved three days after stopping quinine. </p> <p>In the placebo‐controlled trials, there were 1103 unique participants in the meta‐analysis of major adverse events and 969 unique participants in the minor adverse events meta‐analysis (the treatment groups contained many participants from cross‐over trials so the total numbers in both groups should not be summated). On the basis of these, quinine appears to be reasonably safe, but it is not possible to accurately calculate the true incidence of serious or life‐threatening side effects which are rare. A case‐control study in the USA estimated that quinine‐induced thrombocytopenia occurs in 26 of every 1 million users (<a href="./references#CD005044-bbs2-0061" title="KaufmanDW , KellyJP , JohannesCB , SandlerA , HarmonD , StolleyPD , et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood1993;82(9):2714‐8. ">Kaufman 1993</a>). </p> <p>Between 1969 and 1990, 110 serious adverse events with suspected links to quinine were reported to the Food and Drug Administration (<a href="./references#CD005044-bbs2-0048" title="Food , DrugAdministration . Drug products containing quinine for the treatment and/or prevention of malaria for over‐the‐counter human use; proposed rule. Federal Register 19 April 1995;60:19649‐55. ">FDA 1995b</a>). However, the FDA judged that of the 110 reports, only 26 could reasonably be attributed to quinine; 21 of these cases involved quinine doses used in the treatment of leg cramps. There were no cases of overdose, but there were three deaths (<a href="./references#CD005044-bbs2-0048" title="Food , DrugAdministration . Drug products containing quinine for the treatment and/or prevention of malaria for over‐the‐counter human use; proposed rule. Federal Register 19 April 1995;60:19649‐55. ">FDA 1995b</a>). There were six cases of severe skin reactions (two of which were erythema multiforme), 13 'haematological events' (two resulting in death), two cases of hepatitis, two cases of renal failure (one resulting in death, the other dialysis‐dependence), two cases of hypersensitivity syndrome ("chills, nausea, vomiting, diarrhoea"), and one case of anaphylaxis complicated by seizures and hypoxia following a single dose of quinine (<a href="./references#CD005044-bbs2-0048" title="Food , DrugAdministration . Drug products containing quinine for the treatment and/or prevention of malaria for over‐the‐counter human use; proposed rule. Federal Register 19 April 1995;60:19649‐55. ">FDA 1995b</a>). Although this is invaluable information, the incidence of such adverse events still cannot be ascertained as the size of the treated population is unknown and not all serious side effects are reported to the FDA. It is however on the basis of these serious adverse effects that the FDA has banned the marketing of quinine for muscle cramps (<a href="./references#CD005044-bbs2-0049" title="Food , DrugAdministration . Quinine: important warning. www.fda.gov/bbs/topics/news/2006/new01521 12 December 2006 (accessed 20 July 2008). ">FDA 2006</a>) and that the American Academy of Neurology has recommended in their report (<a href="./references#CD005044-bbs2-0060" title="KatzbergHD , KhanAH , SoYT . Assessment: symptomatic treatment for muscle cramps (an evidence‐based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology2010;74(8):691–6. ">Katzberg 2010</a>) that it only be used as a last resort in intractable cramps and with close monitoring. </p> </section> <section id="CD005044-sec-0096"> <h3 class="title" id="CD005044-sec-0096">Haemodialysis and liver cirrhosis</h3> <p>Muscle cramps are more common in people on haemodialysis (<a href="./references#CD005044-bbs2-0042" title="ChouCT , WassersteinA , SchumacherHRJr , FernandezP . Musculoskeletal manifestations in hemodialysis patients. Journal of Rheumatology1985;12(6):1149‐53. ">Chou 1985</a>; <a href="./references#CD005044-bbs2-0062" title="KhajehdehiP , MojerlouM , BehzadiS , Rais‐JalaliGA . A randomized, double‐blind, placebo‐controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps. Nephrology Dialysis Transplantation2001;16(7):1448‐51. ">Khajehdehi 2001</a>) and in those with liver cirrhosis (<a href="./references#CD005044-bbs2-0031" title="AbramsGA , ConcatoJ , FallonMB . Muscle cramps in patients with cirrhosis. American Journal of Gastroenterology1996;91(7):1363‐6. ">Abrams 1996</a>; <a href="./references#CD005044-bbs2-0032" title="AngeliP , AlbinoG , CarraroP , Dalla PriaM , MerkelC , CaregaroL , et al. Cirrhosis and muscle cramps: evidence of a causal relationship. Hepatology1996;23(2):264‐73. ">Angeli 1996</a>). Two trials (<a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>; <a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>) involved participants with cramps related to dialysis, and quinine significantly reduced cramp number in both, along with cramp intensity in one (<a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>), and duration in the other (<a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>). Serum levels of quinine were not monitored, but there were no reports of toxicity with doses of 325 mg daily (<a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a>) and 320 mg thrice weekly (<a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>). The manufacturers of a quinine product (Qualaquin) state that negligible amounts of quinine are removed from the blood during dialysis, and that the half‐life in people with severe renal impairment who are not on dialysis is increased to 26 hours, despite the vast majority of quinine being metabolised by the liver (<a href="./references#CD005044-bbs2-0084" title="Mutual PharmaceuticalCompany . Quinine sulfate [package insert]. Philadelphia, PA: 2006. thomsonweb.esourcegroup.com/files/PI_0.pdf (accessed 2 February 2009). ">Mutual 2006</a>). The manufacturers thus recommend lower doses of quinine in people with severe renal impairment who require treatment for malaria (less than half the normal dose) (<a href="./references#CD005044-bbs2-0084" title="Mutual PharmaceuticalCompany . Quinine sulfate [package insert]. Philadelphia, PA: 2006. thomsonweb.esourcegroup.com/files/PI_0.pdf (accessed 2 February 2009). ">Mutual 2006</a>). </p> <p>One trial included 31 participants with liver cirrhosis and found the optical isomer of quinine, quinidine, to be significantly effective in reducing cramp number, with no sign of serum accumulation (<a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>). The manufacturers of Qualaquin state that although the elimination half‐life is increased in people with mild to moderate hepatic impairment, dosage adjustment is not needed as weight‐adjusted clearance remains the same (<a href="./references#CD005044-bbs2-0084" title="Mutual PharmaceuticalCompany . Quinine sulfate [package insert]. Philadelphia, PA: 2006. thomsonweb.esourcegroup.com/files/PI_0.pdf (accessed 2 February 2009). ">Mutual 2006</a>). </p> </section> <section id="CD005044-sec-0097"> <h3 class="title" id="CD005044-sec-0097">Risk of bias and trial quality</h3> <p>Almost all of the trials included in this meta‐analysis had methodological limitations. As with all meta‐analyses, this leads to exclusion of some trials from some analyses, or the inclusion of data imputed from the published data. Each of the methodological flaws potentially impairs the quality of the data and the power of the meta‐analysis. Specific limitations included inadequate washout periods in cross‐over studies (<a href="./references#CD005044-bbs2-0006" title="DunnNR . Effectiveness of quinine for night cramps. British Journal of General Practice1993;43(368):127‐8. [PUBMED: 8323792] ">Dunn 1993</a>; <a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a>; <a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a>; <a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a>; <a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a>; <a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a>; <a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a>), small number of participants (all but four trials contained less than 100 participants), inadequate explanations of methodology (for example randomisation and blinding), and poor statistical presentation (including lack of mean and standard error figures for outcomes). </p> <p>A common problem was the lack of explanations for drop‐outs and the lack of intention‐to‐treat analyses. Many of the trials failed to elaborate on adverse events, which lie at the heart of the debate of quinine's benefit‐risk ratio. Only four trials (<a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a>; <a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a>; <a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a>; <a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a>) measured serum quinine concentrations, which is not only helpful in determining the dose‐response relationship for muscle cramp, but allows the ceiling effect to be estimated (the level above which the risks of serious adverse events becomes significant). </p> <p>It was impossible to exclude the confounding factor of physiological interventions. Some participants may have used various stretch exercises in addition to their allocated treatment and this may have influenced the outcomes to varying degrees. One study reported that seven out of the 10 participants used stretches to relieve cramp in the acute phase, although the outcomes in this trial did not include cramp duration or intensity (<a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a>). </p> </section> <section id="CD005044-sec-0098"> <h3 class="title" id="CD005044-sec-0098">Other considerations</h3> <p>No study addressed the health economics of quinine; this is most likely because the trials were conducted when quinine was readily and cheaply available in the USA. Recently, however, the cost has risen sharply in the USA due to the FDA's ban on the marketing of quinine for muscle cramps, with the only approved brand being Qualaquin (Mutual Pharmaceutical) for falciparum malaria. Quinine in Europe, however, remains readily available and inexpensive; for instance in the UK each generic 300 mg tablet costs just under GBP 0.08 (USD 0.12). This compares with around USD 5.00 per 324 mg capsule of Qualaquin in the USA (Mutual Pharmaceutical).<br/> <br/> The difference between the USA and Europe with regards to quinine use in muscle cramps is striking. Whilst it can only be used off‐label in the USA for muscle cramps, in the UK quinine is fully licensed and regularly prescribed by general practitioners for people suffering from muscle cramp. It can be bought over the counter in Germany. </p> <p>The British National Formulary (BNF) advises that it may take up to four weeks for the effect on cramp to become apparent and that if there is improvement, then quinine should be taken continuously with close monitoring for adverse events (<a href="./references#CD005044-bbs2-0040" title="Joint Formulary Committee. British National Formulary. 9th Edition. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2010. ">BNF 2010</a>). The BNF also advises interruption of treatment every three months for review of benefit. Some studies have suggested that there are people who benefit from quinine and some who do not (<a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a>; <a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a>); this may be due to inadequate serum concentrations in some, or other factors which have yet to be identified. There is also no current evidence to predict who will suffer serious adverse events, and so it has been suggested that a trial of quinine be used on an individual basis to identify those who will safely benefit from therapy, and prevent others from unnecessary and possibly harmful long‐term medication (<a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a>). </p> <p>It has also been stated that before starting a trial of quinine, reversible causes of cramp such as hypothyroidism, electrolyte imbalance and the presence of cramp‐inducing medication should be considered (<a href="./references#CD005044-bbs2-0053" title="GuayDR . Are there alternatives to the use of quinine to treat nocturnal leg cramps?. Consultant Pharmacist2008;23(2):141‐56. ">Guay 2008</a>; <a href="./references#CD005044-bbs2-0080" title="MillerTM , LayzerRB . Muscle cramps. Muscle and Nerve2005;32(4):431‐42. ">Miller TM 2005</a>). An audit of prescribing patterns in general practice showed that out of 70 people prescribed quinine for muscle cramp, over half were taking medications known to cause cramps (<a href="./references#CD005044-bbs2-0068" title="MackieMA , DavidsonJ . Prescribing of quinine and cramp inducing drugs in general practice. BMJ1995;311(7019):1541. ">Mackie 1995</a>). </p> <p>There is a paucity of data concerning the use of quinine in pregnancy (<a href="./references#CD005044-bbs2-0089" title="NostenF , McGreadyR , d'AlessandroU , BonellA , VerhoeffF , MenendezC , et al. Antimalarial drugs in pregnancy: a review. Current Drug Safety2006;1:1‐15. ">Nosten 2006</a>). Quinine crosses the placenta and is also excreted in breast milk, although breast feeding whilst on quinine is not contraindicated (<a href="./references#CD005044-bbs2-0029" title="Committee on Drugs, American Academy ofPediatrics . The transfer of drugs and other chemicals into human milk. Pediatrics2001;108(3):776‐89. ">AAP 2001</a>). In very high doses, quinine can be teratogenic; in pregnant women who took overdoses of quinine, abortion was very rare but congenital anomalies occurred with central nervous system, limb, facial and cardiac defects (<a href="./references#CD005044-bbs2-0087" title="NishimuraH , TanimuraT . Clinical Aspects of The Teratogenicity of Drugs. Amsterdam: Excerpta Medica, 1976. ">Nishimura 1976</a>), optic nerve hypoplasia and deafness (<a href="./references#CD005044-bbs2-0078" title="McKinnaAJ . Quinine induced hypoplasia of the optic nerve. Canadian Journal of Ophthalmology1966;1(4):261. ">McKinna 1966</a>; <a href="./references#CD005044-bbs2-0081" title="MorgonA , CharachonD , BrinquierN . Disorders of the auditory apparatus caused by embryopathy or foetopathy: prophylaxis and treatment. Acta Otolaryngology (Suppl)1971;291:1‐27. ">Morgon 1971</a>). However, at doses used in malaria, quinine appears to be safe in pregnancy (<a href="./references#CD005044-bbs2-0040" title="Joint Formulary Committee. British National Formulary. 9th Edition. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2010. ">BNF 2010</a>; <a href="./references#CD005044-bbs2-0076" title="McGreadyR ,  ChoT ,  Samuel ,  VillegasL ,  BrockmanA ,  van VugtM ,  etal . Randomized comparison of quinine‐clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Transactions of The Royal Society of Tropical Medicine and Hygiene2001;95(6):651‐6. ">McGready 2001</a>; <a href="./references#CD005044-bbs2-0077" title="McGreadyR ,  ThwaiKL ,  ChoT ,  Samuel ,  LooareesuwanS ,  WhiteNJ ,  etal . The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy. Transactions of The Royal Society of Tropical Medicine and Hygiene2002;96(2):180‐4. ">McGready 2002</a>; <a href="./references#CD005044-bbs2-0088" title="NostenF , McGreadyR , D'AlessandroU , BonellA , VerhoeffF , MenendezC , et al. The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy. Transactions of the Royal Society of Tropical Medicine &amp; Hygiene2002;96:180‐4. ">Nosten 2002</a>; <a href="./references#CD005044-bbs2-0090" title="OrtonLC , OmariAAA . Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD004912.pub3] ">Orton 2008</a>) and does not increase the risk of abortion or preterm delivery (<a href="./references#CD005044-bbs2-0093" title="Phillips‐HowardPA ,  WoodD . The safety of antimalarial drugs in pregnancy. Drug Safety1996;14(3):131‐45. ">Phillips‐Howard 1996</a>). There are, however, the expected side effects on the mother with the high doses used in malaria (<a href="./references#CD005044-bbs2-0094" title="PiolaP ,  NabasumbaC ,  TuryakiraE ,  DhordaM ,  LindegardhN ,  NyehanganeD ,  etal . Efficacy and safety of artemether‐lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open‐label, randomised, non‐inferiority trial. Lancet Infectious Diseases2010;10(11):762‐9. ">Piola 2010</a>). The World Health Organization recommends that quinine be used as first‐line treatment for uncomplicated falciparum malaria in the first trimester of pregnancy, and third‐line treatment in the second and third trimesters because of an increased risk of maternal hypoglycaemia in late pregnancy (<a href="./references#CD005044-bbs2-0100" title="World Health Organization. Guidelines for the treatment of malaria. 2nd Edition. Geneva: WHO Press, 2010. ">WHO 2010</a>). It is likely that the benefits of treatment outweigh the risks when treating pregnant women with malaria, but this may not be the case with muscle cramps. Magnesium salts may be a safer alternative for the treatment of cramps in pregnant women (<a href="./references#CD005044-bbs2-0043" title="DahleLO , BergG , HammarM , HurtigM , LarssonL . The effect of oral magnesium substitution on pregnancy‐induced leg cramps. American Journal of Obstetrics and Gynecology1995;173(1):175‐80. ">Dahle 1995</a>; <a href="./references#CD005044-bbs2-0102" title="YoungGL , JewellD . Interventions for leg cramps in pregnancy. Cochrane Database of Systematic Reviews2002, Issue 1. [DOI: 10.1002/14651858.CD000121] ">Young 2002</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005044-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study. Red = high risk of bias; yellow = unclear risk of bias; green = low risk of bias." data-id="CD005044-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. Red = high risk of bias; yellow = unclear risk of bias; green = low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.2 Difference in number of cramps over 2 weeks ‐ random‐effects (minus Connolly 1992)." data-id="CD005044-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.2 Difference in number of cramps over 2 weeks ‐ random‐effects (minus Connolly 1992). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.7 Participants suffering minor adverse events ‐ fixed‐effect." data-id="CD005044-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.7 Participants suffering minor adverse events ‐ fixed‐effect. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.8 Participants suffering specific minor adverse events." data-id="CD005044-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.8 Participants suffering specific minor adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.9 Participants suffering major adverse events." data-id="CD005044-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.9 Participants suffering major adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.10 Participants suffering specific major adverse events (gastrointestinal)." data-id="CD005044-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Quinine versus placebo, outcome: 1.10 Participants suffering specific major adverse events (gastrointestinal). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Quinine versus vitamin E, outcome: 2.1 Difference in number of cramps in 2 weeks ‐ random‐effects (minus Connolly 1992)." data-id="CD005044-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Quinine versus vitamin E, outcome: 2.1 Difference in number of cramps in 2 weeks ‐ random‐effects (minus Connolly 1992). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), outcome: 3.1 Difference in number of cramps in 2 weeks ‐ random‐effects." data-id="CD005044-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), outcome: 3.1 Difference in number of cramps in 2 weeks ‐ random‐effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Quinine versus placebo, Outcome 1 Difference in number of cramps over 2 weeks (GIV) ‐ fixed‐effect." data-id="CD005044-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Quinine versus placebo, Outcome 1 Difference in number of cramps over 2 weeks (GIV) ‐ fixed‐effect. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Quinine versus placebo, Outcome 2 Difference in number of cramps over 2 weeks ‐ random‐effects (minus Connolly 1992)." data-id="CD005044-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Quinine versus placebo, Outcome 2 Difference in number of cramps over 2 weeks ‐ random‐effects (minus Connolly 1992). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Quinine versus placebo, Outcome 3 Difference in number of cramps according to quinine dose (GIV) ‐ fixed‐effect." data-id="CD005044-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Quinine versus placebo, Outcome 3 Difference in number of cramps according to quinine dose (GIV) ‐ fixed‐effect. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Quinine versus placebo, Outcome 4 Difference in cramp intensity (GIV) ‐ fixed‐effect." data-id="CD005044-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Quinine versus placebo, Outcome 4 Difference in cramp intensity (GIV) ‐ fixed‐effect. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Quinine versus placebo, Outcome 5 Change in cramp duration (min) ‐ random‐effects." data-id="CD005044-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Quinine versus placebo, Outcome 5 Change in cramp duration (min) ‐ random‐effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Quinine versus placebo, Outcome 6 Difference in number of cramp days over 2 weeks (GIV) ‐ random‐effects (minus Connolly 1992." data-id="CD005044-fig-0014" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Quinine versus placebo, Outcome 6 Difference in number of cramp days over 2 weeks (GIV) ‐ random‐effects (minus Connolly 1992. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-001-07.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Quinine versus placebo, Outcome 7 Participants suffering minor adverse events." data-id="CD005044-fig-0015" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Quinine versus placebo, Outcome 7 Participants suffering minor adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-001-08.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Quinine versus placebo, Outcome 8 Participants suffering specific minor adverse events." data-id="CD005044-fig-0016" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Quinine versus placebo, Outcome 8 Participants suffering specific minor adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-001-09.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Quinine versus placebo, Outcome 9 Participants suffering major adverse events." data-id="CD005044-fig-0017" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Quinine versus placebo, Outcome 9 Participants suffering major adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-001-10.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Quinine versus placebo, Outcome 10 Participants suffering specific major adverse events (gastrointestinal)." data-id="CD005044-fig-0018" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Quinine versus placebo, Outcome 10 Participants suffering specific major adverse events (gastrointestinal). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Quinine versus vitamin E, Outcome 1 Difference in number of cramps in 2 weeks ‐ random‐effects (minus Connolly 1992)." data-id="CD005044-fig-0019" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Quinine versus vitamin E, Outcome 1 Difference in number of cramps in 2 weeks ‐ random‐effects (minus Connolly 1992). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Quinine versus vitamin E, Outcome 2 Difference in cramp intensity ‐ fixed‐effect." data-id="CD005044-fig-0020" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Quinine versus vitamin E, Outcome 2 Difference in cramp intensity ‐ fixed‐effect.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Quinine versus vitamin E, Outcome 3 Difference in number of cramp days over 2 weeks ‐ random‐effects (minus Connolly 1992)." data-id="CD005044-fig-0021" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Quinine versus vitamin E, Outcome 3 Difference in number of cramp days over 2 weeks ‐ random‐effects (minus Connolly 1992). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Quinine versus vitamin E, Outcome 4 Participants suffering minor adverse events ‐ random‐effects." data-id="CD005044-fig-0022" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Quinine versus vitamin E, Outcome 4 Participants suffering minor adverse events ‐ random‐effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Quinine versus vitamin E, Outcome 5 Participants suffering major adverse events ‐ random‐effects." data-id="CD005044-fig-0023" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Quinine versus vitamin E, Outcome 5 Participants suffering major adverse events ‐ random‐effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-003-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), Outcome 1 Difference in number of cramps in 2 weeks ‐ random‐effects." data-id="CD005044-fig-0024" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), Outcome 1 Difference in number of cramps in 2 weeks ‐ random‐effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), Outcome 2 Difference in cramp intensity ‐ random‐effects." data-id="CD005044-fig-0025" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), Outcome 2 Difference in cramp intensity ‐ random‐effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), Outcome 3 Difference in number of cramp days over 2 weeks ‐ random‐effects." data-id="CD005044-fig-0026" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), Outcome 3 Difference in number of cramp days over 2 weeks ‐ random‐effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), Outcome 4 Participants suffering minor adverse events ‐ random‐effects." data-id="CD005044-fig-0027" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), Outcome 4 Participants suffering minor adverse events ‐ random‐effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005044-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/urn:x-wiley:14651858:media:CD005044:CD005044-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_t/tCD005044-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), Outcome 5 Participants suffering major adverse events ‐ fixed‐effect." data-id="CD005044-fig-0028" src="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Quinine versus a quinine‐vitamin E combination (Q‐Vel), Outcome 5 Participants suffering major adverse events ‐ fixed‐effect. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/media/CDSR/CD005044/image_n/nCD005044-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005044-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Quinine versus placebo for muscle cramps</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quinine for muscle cramps</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with muscle cramps<br/> <b>Settings:</b> mainly outpatients<br/> <b>Intervention:</b> quinine versus placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Quinine </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of cramps over 2 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the control groups was<br/> <b>8.8 cramps</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the intervention groups was<br/> <b>2.45 lower</b> <br/> (1.36 to 3.54 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>952<br/> (13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cramp intensity</b> <br/> (on 3‐point scale; 1 = mild; 2 = moderate; 3 = severe) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the control groups was<br/> <b>1.2 units</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the intervention groups was<br/> <b>0.12 lower</b> <br/> (0.2 to 0.05 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>666<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering major adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>14 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> (4 to 35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1103<br/> (18 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences. The difference was not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering minor adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>94 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>127 per 1000</b> <br/> (94 to 154) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>969<br/> (16 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences. The difference was statistically significant. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>There were significant shortcomings in study design in some trials, but the majority of those included in this meta‐analysis were of moderate to high quality, warranting a single downgrading for limitations in design and implementation. We further downgraded the evidence for this outcome to low quality because of the heterogeneity of the results.<sup>2</sup>Major adverse events were defined as those being severe enough to warrant participant withdrawal from the trial. As specific hypersensitivity reactions are so rare, larger studies are needed to clarify the incidence of such adverse events in particular. Some trials did not prespecify adverse events as an outcome but simply reported them retrospectively, thus compromising slightly on the quality of evidence.<br/> <sup>3</sup>Minor adverse events were defined as being those that did not warrant participant withdrawal from the trial. Some trials did not prespecify adverse events as an outcome but simply reported them retrospectively, thus compromising slightly on the quality of evidence. Otherwise, a well‐reported outcome. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Quinine versus placebo for muscle cramps</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005044-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Quinine versus vitamin E for muscle cramps</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quinine versus vitamin E for muscle cramps</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with muscle cramps<br/> <b>Settings:</b> outpatients<br/> <b>Intervention:</b> quinine versus vitamin E </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Vitamin E</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Quinine </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of cramps over 2 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the control groups was<br/> <b>7.22</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the intervention groups was<br/> <b>0.24 lower</b> <br/> (1.29 lower to 0.81 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>513<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cramp intensity</b> <br/> (on 3‐point scale; 1 = mild; 2 = moderate; 3 = severe) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the control groups was<br/> <b>1.04 units</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the intervention groups was<br/> <b>0.06 lower</b> <br/> (0.17 lower to 0.04 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>513<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering major adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>9 per 1000</b> <br/> (‐8 to 25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>513<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences. The difference between the 2 groups was not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering minor adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>189 per 1000</b> <br/> (127 to 257) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>483<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences. The difference between the 2 groups was not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Only 3 trials were available for this comparison, 2 of which were conducted by pharmaceutical investigators on behalf of manufacturers of quinine. A deficiency in the design of 1 of these trials meant that there was only a 2‐day washout between cross‐over treatments.<br/> <sup>2</sup>The effect on cramp number was inconsistent among the 3 included trials.<br/> <sup>3</sup>Only 2 studies were available for this comparison; 1 of them having a very short washout period (2 days) between treatments. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Quinine versus vitamin E for muscle cramps</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005044-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Quinine versus a quinine‐vitamin E combination (Q‐Vel) for muscle cramps</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quinine versus a quinine‐vitamin E combination (Q‐Vel) for muscle cramps</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with muscle cramps<br/> <b>Settings:</b> outpatients<br/> <b>Intervention:</b> quinine versus a quinine‐vitamin E combination (Q‐Vel) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Quinine‐vitamin E combination (Q‐Vel)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Quinine </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of cramps over 2 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the control groups was<br/> <b>8.37</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of cramps over 2 weeks in the intervention groups was<br/> <b>1.07 higher</b> <br/> (1.08 lower to 3.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>486<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cramp intensity</b> <br/> (on 3‐point scale; 1 = mild; 2 = moderate; 3 = severe) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the control groups was<br/> <b>0.87 units</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean cramp intensity in the intervention groups was<br/> <b>0.1 higher</b> <br/> (0.06 lower to 0.26 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>510<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference was not statistically significant.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering major adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> <br/> (‐2 to 18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>510<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants suffering minor adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>173 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>202 per 1000</b> <br/> (133 to 273) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>510<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risks were calculated from pooled risk differences. The difference was not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The results for cramp number in these 2 trials were not consistent, each suggesting opposite effects.<br/> <sup>2</sup>Only 2 studies were available for this comparison. Both were conducted by pharmaceutical investigators on behalf of manufacturers of quinine and the quinine‐vitamin E combination.<br/> <sup>3</sup>All 3 trials were conducted by pharmaceutical companies who manufacture quinine and the quinine‐vitamin E combination.<br/> <sup>4</sup>There was no consistency between the results for intensity in these 3 trials. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Quinine versus a quinine‐vitamin E combination (Q‐Vel) for muscle cramps</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005044-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study design of the 23 included trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of participants</b> </p> <p><b>Study design</b> </p> <p><b>Patient focus</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean</b> </p> <p><b>age (yrs)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Female</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Male</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>F: M ratio</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quinine</b> </p> <p><b>dose (mg)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment</b> </p> <p><b>period (d)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Washout period (d)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Treatment comparisons</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0001" title="BioDesign (for Bio ProductsInc.) . Clinical evaluation of Q‐Vel® in patients with nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">BioDesign 1984</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 24</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quinine‐vitamin E combination (Q‐Vel<sup>®</sup>)<sup>b</sup> ✓ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0002" title="BottnerM (for Scholl Inc.) . Clinical trial of the efficacy of quinine sulphate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1984. ">Bottner 1984</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 69</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0003" title="CIBA ConsumerPharmaceuticals . A short‐term randomized, double‐blind parallel study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the prevention and treatment of nocturnal leg cramps. Federal Register, Docket No. 77N‐0094.1988. ">CIBA 1988</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 556</p> <p>Study design = P</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> <p>Vitamin E ✓</p> <p>Quinine‐vitamin E combination (Q‐Vel<sup>®)</sup> ✓ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 30</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> <p>Vitamin E ✓<sup>c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0006" title="DunnNR . Effectiveness of quinine for night cramps. British Journal of General Practice1993;43(368):127‐8. [PUBMED: 8323792] ">Dunn 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 28</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0005" title="DienerHC , DethlefsenU , Dethlefsen‐GruberS , VerbeekP . Effectiveness of quinine in treating muscle cramps: a double‐blind, placebo‐controlled, parallel‐group, multicentre trial. International Journal of Clinical Practice2002;56(4):243‐6. [PUBMED: 12074203] ">Diener 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 94</p> <p>Study design = P</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0007" title="FungMC , HolbrookJH . Placebo‐controlled trial of quinine therapy for nocturnal leg cramps. Western Journal of Medicine1989;151(1):42‐4. [PUBMED: 2669346] ">Fung 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 9</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0008" title="GorlichHD , VonGablenzE , SteinbergHW . Treatment of nocturnal leg cramps. A multicenter, double blind, placebo controlled comparison between the combination of quinine and theophylline ethylene diamine with quinine. Arzneimittel‐Forschung1991;41(2):167‐75. [PUBMED: 2043179] ">Gorlich 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 164</p> <p>Study design = P</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> <p>Quinine‐theophylline combination (Limptar<sup>®</sup>)<sup>b</sup> ✓ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0009" title="HaysRM , Goodman JJ (for SchollInc.) . Clinical trial of the efficacy of quinine sulfate in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Hays 1986</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 62</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0010" title="JansenPH , VeenhuizenKC , VerbeekAL , StraatmanH . Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. Journal of the Neurological Sciences1994;122(2):157‐61. [PUBMED: 8021700] ">Jansen 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 20</p> <p>Study design = P<br/> Patient focus = I </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0011" title="JansenPH , VeenhuizenKC , WesselingAI , DeBooT , VerbeekAL . Randomised controlled trial of hydroquinine in muscle cramps. Lancet1997;349(9051):528‐32. [PUBMED: 9048790] ">Jansen 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 106</p> <p>Study design = P</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0012" title="JonesK , CastledenCM . A double‐blind comparison of quinine sulphate and placebo in muscle cramps. Age and Ageing1983;12(2):155‐8. [PUBMED: 6346830] ">Jones 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 9</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0013" title="KajiDM , AckadA , NottageWG , SteinRM . Prevention of muscle cramps in haemodialysis patients by quinine sulphate. Lancet1976;2(7976):66‐7. [PUBMED: 59150] ">Kaji 1976</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 9</p> <p>Study design = C</p> <p>Patient focus = H</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>320<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0014" title="LeeFY , LeeSD , TsaiYT , LaiKH , ChaoY , LinHC , et al. A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. Journal of Hepatology1991;12(2):236‐40. [PUBMED: 2051002] ">Lee 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 31</p> <p>Study design = P</p> <p>Patient focus = L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0015" title="Leo Winter Associates Inc (for Bio ProductsInc.) . Double blind randomized crossover study of Q‐Vel® versus quinine sulfate versus vitamin E versus placebo in the treatment of nocturnal leg muscle cramps. Federal Register, Docket No. 77N‐0094.1986. ">Leo Winter 1986</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 205</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> <p>Vitamin E ✓</p> <p>Quinine‐vitamin E combination (Q‐Vel<sup>®</sup>) ✓ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0016" title="LimSH . Randomised double‐blind trial of quinine sulphate for nocturnal leg cramp. British Journal of Clinical Practice1986;40(11):462. [PUBMED: 3307858] ">Lim 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 25</p> <p>Study design = P</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≤ 14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0017" title="MauleB . Nocturnal cramp: quinine versus folklore. Practitioner1990;234(1487):420‐1. [PUBMED: 2367299] ">Maule 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 16</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0018" title="PrateepavanichP , KupniratsaikulV , CharoensakT . The relationship between myofascial trigger points of gastrocnemius muscle and nocturnal calf cramps. Journal of the Medical Association of Thailand1999;82(5):451‐9. [PUBMED: 10443094] ">Prateepavanich 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 24</p> <p>Study design = P</p> <p>Patient focus = I<sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Xylocaine injection ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0019" title="RocaAO , JarjouraD , BlendD , CuginoA , RuteckiGW , NuchikatPS , et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO Journal1992;38(3):M481‐5. [PUBMED: 1457907] ">Roca 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 30</p> <p>Study design = P</p> <p>Patient focus = H</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60<sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin E ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0020" title="SidorovJ . Quinine sulfate for leg cramps: does it work?. Journal of the American Geriatrics Society1993;41(5):498‐500. [PUBMED: 8486881] ">Sidorov 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 19</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0021" title="SmithC , JeeR , O'NeillC , DobbsSM . Double‐blind, placebo controlled, cross‐over study of maintenance treatment with quinine bisulphate for night cramps. British Journal of Clinical Pharmacology1986;21(1):108P. ">Smith 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 21</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0022" title="WarburtonA , RoystonJP , O'NeillCJ , NicholsonPW , JeeRD , DenhamMJ , et al. A quinine a day keeps the leg cramps away?. British Journal of Clinical Pharmacology1987;23(4):459‐65. [PUBMED: 3555580] ">Warburton 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 22</p> <p>Study design = C</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005044-bbs2-0023" title="WoodfieldR , Goodyear‐SmithF , ArrollB . N‐of‐1 trials of quinine efficacy in skeletal muscle cramps of the leg. British Journal of General Practice2005;55(512):181‐5. [PUBMED: 15808032] ">Woodfield 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n = 13</p> <p>Study design = N‐of‐1</p> <p>Patient focus = I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200 to 300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo ✓</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>Abbreviations: C: cross‐over, P: parallel, H: haemodialysis‐induced cramps, I: idiopathic, L: patients with liver cirrhosis; n/a: not available </p> <p><sup>a</sup>Unpublished.<br/> <sup>b</sup>Q‐Vel<sup>®</sup>: trade name for quinine‐vitamin E combination; Limptar<sup>®</sup>:trade name for quinine‐theophylline combination.<br/> <sup>c</sup><a href="./references#CD005044-bbs2-0004" title="ConnollyPS , ShirleyEA , WassonJH , NierenbergDW . Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Archives of Internal Medicine1992;152(9):1877‐80. [PUBMED: 1520054] ">Connolly 1992</a> did not directly compare quinine versus vitamin E ‐ using the data provided we were able to draw comparison.<br/> <sup>d</sup>Quinine dose given at beginning of each dialysis session (3 times per wk) and not daily.<br/> <sup>e</sup>Inclusion criteria included presence of myofascial trigger point in gastrocnemius.<br/> <sup>f</sup>A 60‐day trial but results only reported from first month of treatment. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study design of the 23 included trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/full#CD005044-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005044-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Quinine versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Difference in number of cramps over 2 weeks (GIV) ‐ fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp number (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.81 [‐2.20, ‐1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Difference in number of cramps over 2 weeks ‐ random‐effects (minus Connolly 1992) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp Number (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.45 [‐3.54, ‐1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Difference in number of cramps according to quinine dose (GIV) ‐ fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp Number (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.81 [‐2.20, ‐1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 500 mg quinine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp Number (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.7 [‐10.30, ‐7.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 400 mg quinine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp Number (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.36 [‐4.83, ‐1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 300 to 325 mg quinine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp Number (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐1.31, ‐0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 260 mg quinine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp Number (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.29 [‐2.15, ‐0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 200 mg quinine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp Number (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.22 [‐4.40, ‐2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Difference in cramp intensity (GIV) ‐ fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp intensity (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.20, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Change in cramp duration (min) ‐ random‐effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Change in duration (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.35 [‐4.00, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Difference in number of cramp days over 2 weeks (GIV) ‐ random‐effects (minus Connolly 1992 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp days (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.15 [‐1.93, ‐0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Participants suffering minor adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.00, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Participants suffering specific minor adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Gastrointestinal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.01, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Headache</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Tinnitus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.00, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Participants suffering major adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1613</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.01, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Participants suffering specific major adverse events (gastrointestinal) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1613</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.00, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Quinine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005044-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Quinine versus vitamin E</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Difference in number of cramps in 2 weeks ‐ random‐effects (minus Connolly 1992) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>No. cramps (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐1.29, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Difference in cramp intensity ‐ fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp intensity (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.17, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Difference in number of cramp days over 2 weeks ‐ random‐effects (minus Connolly 1992) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp days (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐0.98, 0.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Participants suffering minor adverse events ‐ random‐effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>688</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.04, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Participants suffering major adverse events ‐ random‐effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>748</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.01, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Quinine versus vitamin E</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005044-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Quinine versus a quinine‐vitamin E combination (Q‐Vel)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Difference in number of cramps in 2 weeks ‐ random‐effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>No. cramps (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [‐1.08, 3.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Difference in cramp intensity ‐ random‐effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp intensity (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.06, 0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Difference in number of cramp days over 2 weeks ‐ random‐effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Cramp days (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [‐1.13, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Participants suffering minor adverse events ‐ random‐effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>739</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.04, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Participants suffering major adverse events ‐ fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>739</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.01, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Quinine versus a quinine‐vitamin E combination (Q‐Vel)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005044.pub3/references#CD005044-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005044.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005044-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005044-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD005044-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD005044-note-0002">日本語</a> </li> <li class="section-language"> <a class="" href="pl#CD005044-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="ta#CD005044-note-0005">தமிழ்</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005044\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005044\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005044\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005044\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005044\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uYcNEb5O&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005044.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005044.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005044.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005044.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005044.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726937370"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005044.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726937378"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005044.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e9fd7bf38f480',t:'MTc0MDcyNjkzNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 